|
Lycopodium Limited is an engineering, construction, and project management company founded in 1992. The group operates through four main segments: Resources, Rail Infrastructure, Industrial Processes, and Other. The Resources segment provides engineering and project delivery services to the extractive mining industry, covering commodities such as iron ore, precious metals, base metals, battery metals, and bulk minerals. The Rail Infrastructure segment offers asset management, engineering, and project delivery services to private and public sector clients. The Industrial Processes segment serves manufacturing and renewable energy facilities, with expertise in pharmaceuticals, biotech, chemicals, food and beverage, and energy. Lycopodium serves clients ranging from junior exploration companies to major multinational producers across Australia, Africa, Asia, and the Americas. Notable projects include the Akyem Gold Project, Cobré Panama, and the Hexham Maintenance and Provisioning Facility. The company provides services under EPC and EPCM delivery models, covering feasibility studies, process development, engineering and design, project management, construction management, commissioning, and asset management. Summarised from the company's own disclosures, fiscal year ended Jun 2024 |
Industry Capital Goods | Homepage lycopodium.com |
| Sector Industrials | IR page lycopodium.com/investor-relations | |
|
Tags
mining engineering, rail infrastructure, industrial processes, process engineering, project management, construction management, asset management, feasibility studies, mineral processing, renewable energy, pharmaceuticals, chemicals
|
Press page lycopodium.com/investor-relations/asx-announcements |
Metrics
| Valuation | |
|---|---|
| Market cap | A$ 833.75M |
| Market cap (USD) | $ 565.73M |
| P/E | 20.07 |
| PEG | 0.35 |
| P/BV | 7.21 |
| P/S | 2.57 |
| P/OCF | 44.41 |
| P/FCF | — |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 42.9% |
| ROI | 40.1% |
| ROIC | 40.1% |
| Profit margin | 14.1% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | Yes |
| Revenue up 3y | — |
| Revenue up 5y | — |
| Earnings growth 3y (net profit CAGR) | 57.4% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | Yes |
| Buying back stock | Yes |
| Diluting (TTM) | No |
| Debt/Equity | 0.23% |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 40 |
| Quality score | 53.3% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
| Figure | FY 2023 | FY 2022 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 323.879M | 228.711M | 206.656M | 151.142M | 192.017M | 216.616M | 124.46M | 122.811M | 154.766M | 245.94M | 232.287M | 169.843M | 120.335M |
| Net profit | 45.559M | 26.852M | 11.677M | 16.399M | 18.659M | 10.374M | 3.326M | -1.015M | 3.709M | 22.54M | 22.355M | 17.113M | 16.058M |
Podcast Mentions
Announcements lodged with ASX, newest first, routine forms (director and substantial-holding notices, daily buy-back and quotation notices) included. The link opens the announcement on ASX. Press releases from the company's own website, newest first.
Lycopodium Limited ABN 83 098 556 159 W lycopodium.com
Level 5, 1 Adelaide Terrace, East Perth WA 6004, Australia T +61 8 6210 5222
Lycopodium Limited (ASX: LYL) Annual General Meeting
PERTH, 9 October 2026
Notice is hereby given that the Annual General Meeting of the shareholders of Lycopodium Limited
(ASX: LYL) (Company) will be held at Lycopodium, Level 5, 1 Adelaide Terrace, East Perth, Western
Australia on Thursday, 12 November 2026 at 10:30am (AWST) (Meeting).
Notice of Meeting
In accordance with section 110D(1) of the Corporations Act 2001 (Cth) (the Corporations Act), the
Company is not sending hard copies of the Notice of Meeting to shareholders unless a shareholder
has requested a hard copy of the Notice of Meeting or made an election for the purposes of section
110E of the Corporations Act to receive documents from the Company in physical form. The Notice of
Meeting can be viewed and downloaded from
https://www.lycopodium.com/investor-relations/asx-
announcements/.
The Notice is important and should be read in its entirety. If you are in doubt as to the course of
action you should follow, you should consult your financial adviser, lawyer, accountant or other
professional adviser.
If you have any difficulties accessing the Notice, please contact the Company’s share registry,
Computershare Investor Services Pty Limited, on 1300 764 130 (within Australia) or +61 3 9415 4267
(outside Australia).
Investors who are unable or choose not to attend the Meeting can view the AGM presentation which
will be available on the Company’s website
https://www.lycopodium.com/investor-relations/asx-
announcements/ prior to the Meeting.
Proxy Lodgements
If you have not elected to receive notices from the Company by email, a copy of your personalised
proxy form will be sent to you by mail enclosed with this letter.
Shareholders are encouraged to submit proxy votes either online at
www.investorvote.com.au or by
returning the enclosed proxy form as per the options below:
Post: Computershare Investor Services Pty Limited
GPO Box 242
MELBOURNE VIC 3001
OR
Fax: 1800 783 447 (within Australia)
+61 3 9473 2555 (outside Australia)
Lycopodium Limited ABN 83 098 556 159 W lycopodium.com
Level 5, 1 Adelaide Terrace, East Perth WA 6004, Australia T +61 8 6210 5222
Your proxy voting instruction must be received by 10:30am (AWST) on Tuesday, 10 November 2026,
being not less than 48 hours before the commencement of the Meeting. Any proxy voting
instructions received after that time will not be valid for the Meeting.
In order to be able to receive electronic communications from the Company in the future, please
update your shareholder details online at
www.investorcentre.com/au.
About Lycopodium Limited (ASX: LYL)
Lycopodium is a leader in its field, working with clients to provide integrated engineering, project,
construction and asset management solutions. We have the expertise to deliver complex,
multidisciplinary projects, through to the provision of feasibility studies and advisory services.
Operating across the Resources, Industrial Processes and Rail Infrastructure industries, we offer a
diverse team of industry experts to deliver bespoke and innovative solutions across all commodity
types.
With the capability to deliver projects around the world, we have offices in Australia, Canada, USA,
Argentina, Brazil, Peru, South Africa, Namibia, Botswana, Tanzania, Ghana and the Philippines.
For more, visit
www.lycopodium.com
LYCOPODIUM LIMITED ACN 098 556 159 NOTICE OF ANNUAL GENERAL MEETING
Notice is given that the Meeting will be held at:
TIME: 12 November 2026 (AWST)
DATE: 10.30am
PLACE: Level 5
1 Adelaide Terrace
EAST PERTH WA 6004
The business of the Meeting affects your shareholding and your vote is important.
This Notice should be read in its entirety. If Shareholders are in doubt as to how they should vote, they
should seek advice from their professional advisers prior to voting.
The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001
(Cth) that the persons eligible to vote at the Meeting are those who are registered Shareholders at
4.00pm (AWST) on 10 November 2026.
1
BUSINESS OF THE MEETING
FINANCIAL STATEMENTS AND REPORTS
To receive and consider the annual financial report of the Company for the financial year ended 30 June 2026
together with the declaration of the Directors, the Director’s report, the Remuneration Report and the
auditor’s report.
- RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT To consider and, if thought fit, to pass, with or without amendment, the following resolution as a non-binding resolution: “That, for the purposes of section 250R(2) of the Corporations Act and for all other purposes, approval is given for the adoption of the Remuneration Report as contained in the Company’s annual financial report for the financial year ended 30 June 2026.” Note: the vote on this Resolution is advisory only and does not bind the Directors or the Company.
- RESOLUTION 2 – RE-ELECTION OF DIRECTOR - MR BRUNO RUGGIERO
To consider and, if thought fit, to pass, with or without amendment, the following resolution as an
ordinary resolution:
“That, for the purpose of clause 14.2 of the Constitution, Listing Rule 14.4 and for all other
purposes, Mr Bruno Ruggiero, a Director, retires by rotation, and being eligible, is re-elected as a Director.” - RESOLUTION 3 – RE-ELECTION OF DIRECTOR - MR KARL CICANESE To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution: “That, for the purpose of clause 14.2 of the Constitution, and for all other purposes, Mr Karl Cicanese, a Director, retires by rotation, and being eligible, is re-elected as a Director.”
- RESOLUTION 4 – ISSUE OF PERFORMANCE RIGHTS TO MR PETER DE LEO To consider and, if thought fit, to pass the following resolution as an ordinary resolution: “That, for the purposes of Listing Rule 10.14 and for all other purposes, approval is given for the Company to issue 11,629 Performance Rights to Mr Peter De Leo (or his nominee(s)) under the Plan on the terms and conditions set out in the Explanatory Statement.”
- RESOLUTION 5 – ISSUE OF PERFORMANCE RIGHTS TO MR BRUNO RUGGIERO
To consider and, if thought fit, to pass the following resolution as an ordinary resolution: “Subject to the passing of Resolution 2, that, for the purposes of Listing Rule 10.14 and for all other purposes, approval is given for the Company to issue 9,967 Performance Rights to Mr Bruno Ruggiero (or his nominee(s)) under the Plan on the terms and conditions set out in the Explanatory Statement.” - RESOLUTION 6 – ISSUE OF PERFORMANCE RIGHTS TO MR KARL CICANESE To consider and, if thought fit, to pass the following resolution as an ordinary resolution: “Subject to the passing of Resolution 3, that, for the purposes of Listing Rule 10.14 and for all other purposes, approval is given for the Company to issue 10,693 Performance Rights to Mr Karl Cicanese (or his nominee(s)) under the Plan on the terms and conditions set out in the Explanatory Statement.”
2
- RESOLUTION 7 – INCREASE IN TOTAL AGGREGATE REMUNERATION FOR NON-EXECUTIVE
DIRECTORS To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution: “That, for the purposes of clause 14.8 of the Constitution, Listing Rule 10.17 and for all other purposes, Shareholders approve an increase of the total aggregate amount of fees payable to non-executive Directors from $640,000 per annum to $800,000 per annum in accordance with the terms and conditions set out in the Explanatory Statement.” Dated: 9 October 2026
Justine Campbell Company Secretary
3
Voting Prohibition Statements
Resolution 1 – Adoption of
Remuneration Report
A vote on this Resolution must not be cast (in any capacity) by or on behalf of either of
the following persons:
(a) a member of the Key Management Personnel, details of whose
remuneration are included in the Remuneration Report; or
(b) a Closely Related Party of such a member.
However, a person (the voter) described above may cast a vote on this Resolution as a
proxy if the vote is not cast on behalf of a person described above and either:
(a) the voter is appointed as a proxy by writing that specifies the way the proxy
is to vote on this Resolution; or
(b) the voter is the Chair and the appointment of the Chair as proxy:
(i) does not specify the way the proxy is to vote on this Resolution;
and
(ii) expressly authorises the Chair to exercise the proxy even though
this Resolution is connected directly or indirectly with the
remuneration of a member of the Key Management Personnel.
Resolution 4– Approval to issue
Performance Rights to Mr Peter
De Leo
A person appointed as a proxy must not vote, on the basis of that appointment, on this
Resolution if:
(a) the proxy is either:
(i) a member of the Key Management Personnel; or
(ii) a Closely Related Party of such a member; and
(b) the appointment does not specify the way the proxy is to vote on this
Resolution.
However, the above prohibition does not apply if:
(a) the proxy is the Chair; and
(a) the appointment expressly authorises the Chair to exercise the proxy even
though this Resolution is connected directly or indirectly with remuneration
of a member of the Key Management Personnel.
Resolution 5 – Approval to issue
Performance Rights to Mr Bruno
Ruggiero
A person appointed as a proxy must not vote, on the basis of that appointment, on this
Resolution if:
(b) the proxy is either:
(i) a member of the Key Management Personnel; or
(ii) a Closely Related Party of such a member; and
(c) the appointment does not specify the way the proxy is to vote on this
Resolution.
However, the above prohibition does not apply if:
(a) the proxy is the Chair; and
(b) the appointment expressly authorises the Chair to exercise the proxy even
though this Resolution is connected directly or indirectly with remuneration
of a member of the Key Management Personnel.
Resolution 6– Approval to issue
Performance Rights to Mr Karl
Cicanese
A person appointed as a proxy must not vote, on the basis of that appointment, on this
Resolution if:
(a) the proxy is either:
(i) a member of the Key Management Personnel; or
(ii) a Closely Related Party of such a member; and
(b) the appointment does not specify the way the proxy is to vote on this
Resolution.
However, the above prohibition does not apply if:
(a) the proxy is the Chair; and
(b) the appointment expressly authorises the Chair to exercise the proxy even
though this Resolution is connected directly or indirectly with remuneration
of a member of the Key Management Personnel.
Resolution 7 - Increase in total
aggregate remuneration for
Non-Executive Directors
A person appointed as a proxy must not vote, on the basis of that appointment, on this
Resolution if:
(a) the proxy is either:
(i) a member of the Key Management Personnel; or
(ii) a Closely Related Party of such a member; and
(b) the appointment does not specify the way the proxy is to vote on this
Resolution.
However, the above prohibition does not apply if:
(a) the proxy is the Chair; and
(b) the appointment expressly authorises the Chair to exercise the proxy even
though this Resolution is connected directly or indirectly with remuneration
of a member of the Key Management Personnel.
4
Voting Exclusion Statements
In accordance with Listing Rule 14.11, the Company will disregard any votes cast in favour of the Resolution
set out below by or on behalf of the following persons:
Resolution 4 – Approval to issue
Performance Rights to Mr Peter
De Leo
Mr Peter De Leo (or his nominee(s)) and any other person referred to in Listing Rule
10.14.1, 10.14.2 or 10.14.3 who is eligible to participate in the employee incentive
scheme in question or an associate of that person or those persons.
Resolution 5 – Approval to issue
Performance Rights to Mr Bruno
Ruggiero
Mr Bruno Ruggiero (or his nominee(s)) and any other person referred to in Listing Rule
10.14.1, 10.14.2 or 10.14.3 who is eligible to participate in the employee incentive
scheme in question or an associate of that person or those persons.
Resolution 6 – Approval to issue
Performance Rights to Mr Karl
Cicanese
Mr Karl Cicanese (or his nominee(s)) and any other person referred to in Listing Rule
10.14.1, 10.14.2 or 10.14.3 who is eligible to participate in the employee incentive
scheme in question or an associate of that person or those persons.
Resolution 7 - Increase in total
aggregate remuneration for
Non-Executive Directors
A Director or an associate of that person or those persons.
However, this does not apply to a vote cast in favour of the Resolution by:
(a) a person as a proxy or attorney for a person who is entitled to vote on the Resolution, in accordance
with the directions given to the proxy or attorney to vote on the Resolution in that way; or
(b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance
with a direction given to the Chair to vote on the Resolution as the Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a
beneficiary provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is not
excluded from voting, and is not an associate of a person excluded from voting, on the
Resolution; and
(ii) the holder votes on the Resolution in accordance with directions given by the beneficiary
to the holder to vote in that way.
5
Voting by proxy
To vote by proxy, please complete and sign the enclosed Proxy Form and return by the time and in accordance
with the instructions set out on the Proxy Form.
In accordance with section 249L of the Corporations Act, Shareholders are advised that:
• each Shareholder has a right to appoint a proxy;
• the proxy need not be a Shareholder of the Company; and
• a Shareholder who is entitled to cast two or more votes may appoint two proxies and may specify
the proportion or number of votes each proxy is appointed to exercise. If the Shareholder appoints
two proxies and the appointment does not specify the proportion or number of the member’s votes,
then in accordance with section 249X(3) of the Corporations Act, each proxy may exercise one-half
of the votes.
Shareholders and their proxies should be aware that:
• if proxy holders vote, they must cast all directed proxies as directed; and
• any directed proxies which are not voted will automatically default to the Chair, who must vote the
proxies as directed.
Voting in person
To vote in person, attend the Meeting at the time, date and place set out above.
You may still attend the Meeting and vote in person even if you have appointed a proxy. If you have previously
submitted a Proxy Form, your attendance will not revoke your proxy appointment unless you actually vote at
the Meeting for which the proxy is proposed to be used, in which case, the proxy’s appointment is deemed
to be revoked with respect to voting on that Resolution.
Please bring your personalised Proxy Form with you as it will help you to register your attendance at the
Meeting. If you do not bring your Proxy Form with you, you can still attend the Meeting but representatives
from Computershare will need to verify your identity. You can register from 10:00 am (WST) on the day of the
Meeting.
Should you wish to discuss the matters in this Notice please do not hesitate to contact the Company
Secretary on +61 8 6210 5222.
6
EXPLANATORY STATEMENT
This Explanatory Statement has been prepared to provide information which the Directors believe to be
material to Shareholders in deciding whether or not to pass the Resolutions.
- FINANCIAL STATEMENTS AND REPORTS
In accordance with the Corporations Act, the business of the Meeting will include receipt and
consideration of the annual financial report of the Company for the financial year ended
30 June 2026 together with the declaration of the Directors, the Directors’ report, the Remuneration Report and the auditor’s report. The Company will not provide a hard copy of the Company’s annual financial report to Shareholders unless specifically requested to do so. The Company’s annual financial report is available on its
website at www.lycopodium.com. - RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT
2.1 General
The Corporations Act requires that at a listed company’s annual general meeting, a resolution that
the remuneration report to be adopted must be put to the shareholders. However, such a resolution
is advisory only and does not bind the company or the directors of the company.
The remuneration report sets out the company’s remuneration arrangements for the directors and senior management of the company. The remuneration report is part of the directors’ report
contained in the annual financial report of the company for a financial year. The chair of the meeting must allow a reasonable opportunity for its shareholders to ask questions about or make comments on the remuneration report at the annual general meeting. 2.2 Voting consequences A company is required to put to its shareholders a resolution proposing the calling of another
meeting of shareholders to consider the appointment of directors of the company
(Spill Resolution) if, at consecutive annual general meetings, at least 25% of the votes cast on a remuneration report resolution are voted against adoption of the remuneration report and at the first of those annual general meetings a Spill Resolution was not put to vote. If required, the Spill Resolution must be put to vote at the second of those annual general meetings. If more than 50% of votes cast are in favour of the Spill Resolution, the company must convene a shareholder meeting (Spill Meeting) within 90 days of the second annual general meeting. All of the directors of the company who were in office when the directors' report (as included in the company’s annual financial report for the most recent financial year) was approved, other than the managing director of the company, will cease to hold office immediately before the end of the Spill Meeting but may stand for re-election at the Spill Meeting. Following the Spill Meeting those persons whose election or re-election as directors of the company is approved will be the directors of the company. 2.3 Previous voting results At the Company’s previous annual general meeting the votes cast against the remuneration report considered at that annual general meeting were less than 25%. Accordingly, the Spill Resolution is not relevant for this Meeting. - RESOLUTION 2 – RE-ELECTION OF DIRECTOR – MR BRUNO RUGGIERO
3.1 General Listing Rule 14.4 and clause 14.2 of the Constitution provide that, other than a managing director, a director of an entity must not hold office (without re-election) past the third annual general
meeting following the director’s appointment or three years, whichever is the longer. However,
7
where there is more than one managing director, only one is entitled to be exempt from this
rotation requirement.
Mr Ruggiero, having held office without re-election since 14 November 2023 and being eligible,
retires by rotation and seeks re-election.
Further information in relation to Mr Ruggiero is set out below.
Qualifications,
experience and other
material directorships
Mr Ruggiero (BE (Mech), Grad Dip Min Sc, Grad Cert Eng Tech,
MIEAust) has over 30 years’ experience in the minerals industry. He
currently serves as the Group Technical Director for Lycopodium
Limited having overarching responsibility for the Company’s technical
knowledge base, capabilities and direction. Mr Ruggiero is an
executive Director of the Company and a member of the Company’s
corporate governance and risk committees. Mr Ruggiero is also a
director of Lycopodium (APAC) Pty Ltd.
Mr Ruggiero is currently non-executive director of ECG Engineering
Pty Ltd and non-executive director of Quantum Graphite Limited.
Term of office Mr Ruggiero has served as a Director since 25 October 2001 and was
last re-elected on 14 November 2023.
Independence If re-elected, the Board does not consider that Mr Ruggiero will be an
independent Director.
Board
recommendation
Having received an acknowledgement from Mr Ruggiero that they
will have sufficient time to fulfil their responsibilities as a Director and
having reviewed the performance of Mr Ruggiero since their
appointment to the Board and the skills, knowledge, experience and
capabilities required by the Board, the Directors (other than Mr
Ruggiero) recommend that Shareholders vote in favour of this
Resolution.
3.2 Technical information required by Listing Rule 14.1A
If this Resolution is passed, Mr Ruggiero will be re-elected to the Board as an executive Director.
If this Resolution is not passed, Mr Ruggiero will not continue in his role as an executive Director.
The Company may seek nominations or otherwise identify suitably qualified candidates to join the
Company. As an additional consequence, this may detract from the Board and Company’s ability to
execute on its strategic vision.
4. RESOLUTION 3 – RE-ELECTION OF DIRECTOR – MR KARL CICANESE
4.1 General
The Constitution sets out the requirements for determining which Directors are to retire by rotation
at an annual general meeting.
Mr Karl Cicanese, who has held office without re-election since 12 November 2024, and being
eligible retires by rotation and seeks re-election.
Further information in relation to Mr Cicanese is set out below.
Qualifications,
experience and
other material
directorships
Mr Cicanese (MBA, FAusIMM) has over 30 years’ industry experience in
engineering and construction, with in-depth knowledge of the
Lycopodium business, having held a number of senior roles within
Lycopodium (APAC) Pty Ltd, including general manager, group manager
and project director. Mr Cicanese is an executive Director of the
Company and a member of the Company’s corporate governance
committee.
8
Mr Cicanese is currently managing director of Lycopodium (APAC) Pty
Ltd and also serves as the non-executive director of Mondium Pty Ltd.
Term of office
Mr Cicanese has served as a Director since 23 November 2020 and was
last re-elected on 12 November 2024.
Independence If re-elected, the Board does not consider that that Mr Cicanese will be
an independent Director.
Board
recommendation
Having received an acknowledgement from Mr Cicanese that they will
have sufficient time to fulfil their responsibilities as a Director and having
reviewed the performance of Mr Cicanese since their appointment to
the Board and the skills, knowledge, experience and capabilities
required by the Board, the Directors (other than Mr Cicanese)
recommend that Shareholders vote in favour of this Resolution.
4.2 Technical information required by Listing Rule 14.1A
If this Resolution is passed, Mr Cicanese will be re-elected to the Board as an executive Director.
If this Resolution is not passed, Mr Cicanese will not continue in their role as an executive Director.
The Company may seek nominations or otherwise identify suitably qualified candidates to join the
Company. As an additional consequence, this may detract from the Board and Company’s ability to
execute on its strategic vision.
5. RESOLUTIONS 4 TO 6 – ISSUE OF PERFORMANCE RIGHTS TO RELATED PARTIES
5.1 General
These Resolutions seek Shareholder approval for the purposes of Listing Rule 10.14 for the issue of
an aggregate of 32,289 Performance Rights to Mr Peter De Leo, Mr Bruno Ruggiero and Mr Karl
Cicanese (or their nominee(s)) (together, the Related Parties) pursuant to the Incentive Plan (Plan)
on the terms and conditions set out below.
Further details in respect of the Performance Rights proposed to be issued are set out in the table
below.
RELATED PARTY RESOLUTION PERFORMANCE
RIGHTS
VESTING DATE EXPIRY DATE
Peter De Leo 4
11,629
3 years after the
date of grant
12 November
2031
Bruno Ruggiero 5
9,967
3 years after the
date of grant
12 November
2031
Karl Cicanese 6 10,693
3 years after the
date of grant
12 November
2031
TOTAL
32,289
The issue of Performance Rights to Mr Bruno Ruggiero and Mr Karl Cicanese under Resolutions 5
and 6 respectively are subject to Mr Ruggiero and Mr Cicanese being re-elected as a Director under
Resolutions 2 and 3 respectively.
5.2 Chapter 2E of the Corporations Act
Chapter 2E of the Corporations Act requires that for a public company, or an entity that the public
company controls, to give a financial benefit to a related party of the public company, the public
company or entity must:
9
(a) obtain the approval of the public company’s members in the manner set out in sections
217 to 227 of the Corporations Act; and
(b) give the benefit within 15 months following such approval,
unless the giving of the financial benefit falls within an exception set out in sections 210 to 216 of
the Corporations Act.
The issue constitutes giving a financial benefit and the Related Parties are each a related party of
the Company by virtue of being a Director.
The Directors (other than Mr Peter De Leo, Mr Bruno Ruggiero and Mr Karl Cicanese) consider that
Shareholder approval pursuant to Chapter 2E of the Corporations Act is not required in respect of
the issue, because the agreement to issue the Performance Rights, reached as part of the
remuneration package for the Related Parties, is considered reasonable remuneration in the
circumstances and was negotiated on an arm’s length basis.
5.3 Listing Rule 10.14
Listing Rule 10.14 provides that an entity must not permit any of the following persons to acquire
equity securities under an employee incentive scheme without the approval of the holders of its
ordinary securities:
10.14.1 a director of the entity;
10.14.2 an associate of a director of the entity; or
10.14.3
a person whose relationship with the entity or a person referred to in Listing Rules
10.14.1 to 10.14.2 is such that, in ASX’s opinion, the acquisition should be approved
by security holders.
The issue falls within Listing Rule 10.14.1 and therefore requires the approval of Shareholders under
Listing Rule 10.14.
5.4 Technical information required by Listing Rule 14.1A
If these Resolutions are passed, the Company will be able to proceed with the issue within 15
months after the date of the Meeting. As approval pursuant to Listing Rule 7.1 is not required for
the issue (because approval is being obtained under Listing Rule 10.14), the issue will not use up
any of the Company’s 15% annual placement capacity.
If these Resolutions are not passed, the Company will not be able to proceed with the issue.
5.5 Technical information required by Listing Rule 10.15
REQUIRED
INFORMATION
DETAILS
Name of the person to
whom Securities will be
issued
Mr Peter De Leo, Mr Bruno Ruggiero and Mr Karl Cicanese.
Categorisation under
Listing Rule 10.14
The Related Parties fall within the category set out in Listing
Rule 10.14.1 as they are each a related party of the Company by
virtue of being a Director.
Any nominee(s) of the Related Parties who receive Securities may
constitute ‘associates’ for the purposes of Listing Rule 10.14.2.
Number of Securities and
class to be issued
A total of 32,289 Performance Rights will be issued.
Remuneration package The current total remuneration packages for the Related Parties
are set out in the table below:
10
REQUIRED
INFORMATION
DETAILS
RELATED PARTY FY ENDING
30 JUNE 2027
REMUNERATION
PACKAGE PRE
ISSUE
FY ENDING
30 JUNE 2027
REMUNERATION
PACKAGE POST
ISSUE
1
Peter De Leo $1,051,164
$1,259,439 Bruno Ruggiero $878,761
$1,057,270 Karl Cicanese $961,317
$1,152,829 Notes:
- Valuation based on the Binomial Tree methodology set out below.
- Increase in FY27 remuneration package of $208,275 being the value of the Performance Rights proposed to be issued to Mr Peter De Leo.
- Increase in FY27 remuneration package of $178,509 being the value of the Performance Rights proposed to be issued to Mr Bruno Ruggiero.
- Increase in FY27 remuneration package of $191,512 being the value of
the Performance Rights proposed to be issued to Mr Karl Cicanese.
Securities previously
issued to the recipient/(s)
under the Plan
The Plan was approved by Shareholders at the Company’s annual
general meeting held on 13 November 2025. The following
Performance Rights have previously been issued to the Related
Parties for nil cash consideration under the Plan: Mr Karl Cicanese – 12,544 Performance Rights. Mr Bruno Ruggiero – 11,836 Performance Rights; and Mr Peter De Leo – 14,022 Performance Rights. Terms of Securities The Performance Rights will be issued on the terms and conditions set out in Schedule 1. Consideration of type of Security to be issued The Company has agreed to issue the Performance Rights for the following reasons: (a) the issue of the Performance Rights has no immediate dilutionary impact on Shareholders; (b) the issue to the Related Parties will align the interests of the recipient with those of Shareholders; (c) the issue is a reasonable and appropriate method to
provide cost effective remuneration as the non-cash
form of this benefit will allow the Company to spend a greater proportion of its cash reserves on its operations than it would if alternative cash forms of remuneration were given to the Related Parties; and (d) it is not considered that there are any significant
opportunity costs to the Company or benefits foregone by the Company in issuing the Incentive Performance
Rights on the terms proposed. Valuation The Company values the Performance Rights at $578,296 (being $17.91 per Performance Right) based on the Binomial Tree
methodology. Date(s) on or by which the Securities will be issued The Company expects to issue the Performance Rights within 5
Business Days of the Meeting. In any event, the Company will not issue any Performance Rights later than three years after the date
11
REQUIRED
INFORMATION
DETAILS
of the Meeting (or such later date to the extent permitted by any
ASX waiver or modification of the Listing Rules).
Issue price of Securities The Performance Rights will be issued at a nil issue price.
Material terms of the Plan A summary of the material terms and conditions of the Plan is set
out in Schedule 2.
Material terms of any
loan
No loan is being made in connection with the acquisition of the
Performance Rights.
Additional Information Details of any Performance Rights issued under the Plan will be
published in the annual report of the Company relating to the
period in which they were issued, along with a statement that
approval for the issue was obtained under Listing Rule 10.14.
Any additional persons covered by Listing Rule 10.14 who become
entitled to participate in an issue of Performance Rights under the
Plan after this Resolution is approved and who were not named in
this Notice will not participate until approval is obtained under
Listing Rule 10.14.
Voting exclusion
statement
A voting exclusion statement applies to this Resolution.
Voting prohibition
statement.
A voting prohibition statement applies to this Resolution.
- RESOLUTION 7 – INCREASE IN TOTAL AGGREGATE REMUNERATION FOR NON-EXECUTIVE
DIRECTORS
6.1 General This Resolution seeks Shareholder approval for the purposes of clause 14.8 of the Constitution and Listing Rule 10.17 to increase the total aggregate amount of fees payable to non-executive Directors from $640,000 to $800,000. Listing Rule 10.17 provides that an entity must not increase the total aggregate amount of directors’ fees payable to all of its non-executive directors without the approval of holders of its ordinary
securities. Directors’ fees include all fees payable by the entity or any of its child entities to a non-executive director for acting as a director of the entity or any of its child entities (including attending and
participating in any board committee meetings), superannuation contributions for the benefit of a non-executive director and any fees which a non-executive director agrees to sacrifice for other
benefits. It does not include reimbursement of genuine out of pocket expenses, genuine “special exertion” fees paid in accordance with an entity’s constitution, or securities issued to a non- executive director under Listing Rules 10.11 or 10.14 with the approval of the holders of its ordinary securities. Clause 14.8 of the Constitution provides that total aggregate fixed sum payable to the non- executive Directors may be varied by ordinary resolution of Shareholders in a general meeting. 6.2 Technical information required by Listing Rule 14.1A If this Resolution is passed, the maximum aggregate amount of fees payable to the non-executive Directors will increase by $160,000 to $800,000.
12
If this Resolution is not passed, the maximum aggregate amount of fees payable to non-executive
Directors will remain at $640,000. This may inhibit the ability of the Company to remunerate, attract
and retain appropriately skilled non-executive directors.
6.3 Technical information required by Listing Rule 10.17
REQUIRED
INFORMATION
DETAILS
Maximum aggregate
amount of director’s fees
This Resolution seeks to increase the maximum aggregate
amount of fees payable to the non-executive Directors by an
amount of $160,000 to $800,000.
This amount has been determined after reviewing similar
companies listed on ASX and the Directors believe that this level
of remuneration is in line with corporate remuneration of similar
companies.
Whilst it is not envisaged that the maximum amount sought will
be utilised immediately, the increase to maximum aggregate
amount of fees payable may enable the Company to:
(e) fairly remunerate both existing and any new non-
executive directors joining the Board;
(f) remunerate its non-executive Directors appropriately
for the expectations placed upon them both by the
Company and the regulatory environment in which it
operates; and
(g) have the ability to attract and retain non-executive
directors whose skills and qualifications are appropriate
for a company of the size and nature of the Company.
Securities issued to non-
executive Directors
In the past three years, the Company has not issued any Securities
to non-executive Directors pursuant to Listing Rules 10.11 and
10.14.
Voting exclusion
statement
A voting exclusion statement applies to this Resolution
Voting prohibition
statement
A voting prohibition statement applies to this Resolution
6.4 Board Recommendation
Given the interest of the non-executive Directors in this Resolution, the Board makes no
recommendation to Shareholders regarding this Resolution.
13
GLOSSARY
$ means Australian dollars.
ASIC means the Australian Securities & Investments Commission.
ASX means ASX Limited (ACN 008 624 691) or the financial market operated by ASX Limited, as the context
requires.
Board means the current board of directors of the Company.
Business Day means Monday to Friday inclusive, except New Year’s Day, Good Friday, Easter Monday,
Christmas Day, Boxing Day, and any other day that ASX declares is not a business day.
Chair means the chair of the Meeting.
Closely Related Party of a member of the Key Management Personnel means:
(a) a spouse or child of the member;
(b) a child of the member’s spouse;
(c) a dependent of the member or the member’s spouse;
(d) anyone else who is one of the member’s family and may be expected to influence the member, or
be influenced by the member, in the member’s dealing with the entity;
(e) a company the member controls; or
(f) a person prescribed by the Corporations Regulations 2001 (Cth) for the purposes of the definition
of ‘closely related party’ in the Corporations Act.
Company means Lycopodium Limited (ACN 098 556 159).
Constitution means the Company’s constitution.
Corporations Act means the Corporations Act 2001 (Cth).
Directors means the current directors of the Company.
Explanatory Statement means the explanatory statement accompanying the Notice.
Key Management Personnel has the same meaning as in the accounting standards issued by the Australian
Accounting Standards Board and means those persons having authority and responsibility for planning,
directing and controlling the activities of the Company, or if the Company is part of a consolidated entity, of
the consolidated entity, directly or indirectly, including any director (whether executive or otherwise) of the
Company, or if the Company is part of a consolidated entity, of an entity within the consolidated group.
Listing Rules means the Listing Rules of ASX.
Managing Director means the managing director of the Company who may, in accordance with the Listing
Rules, continue to hold office indefinitely without being re-elected to the office.
Meeting means the meeting convened by the Notice.
Notice means this notice of meeting including the Explanatory Statement and the Proxy Form.
Option means an option to acquire a Share.
Performance Right means a right to acquire a Share subject to satisfaction of performance milestones.
Proxy Form means the proxy form accompanying the Notice.
Related Parties has the meaning given in Section 5.1.
Remuneration Report means the remuneration report set out in the Director’s report section of the
Company’s annual financial report for the year ended 30 June 2026.
14 Resolutions means the resolutions set out in the Notice, or any one of them, as the context requires. Section means a section of the Explanatory Statement. Security means a Share, Option or Performance Right. Share means a fully paid ordinary share in the capital of the Company. Shareholder means a registered holder of a Share. WST means Western Standard Time as observed in Perth, Western Australia.
15 SCHEDULE 1 – TERMS AND CONDITIONS OF PERFORMANCE RIGHTS
- Entitlement Each Performance Right entitles the holder to subscribe for one Share upon conversion of the Performance Right.
- Plan
The Performance Rights are granted under the Company's Incentive
Performance Rights Plan (Plan).
Defined terms in these terms and conditions have the same meaning as in the Plan. In the event of any inconsistency between the Plan and these terms and conditions, these terms and conditions will apply to the extent of the inconsistency. - Consideration Nil consideration is payable for the Performance Rights.
- Expiry Date Each Performance Right will expire on the earlier to occur of:
(a) the Performance Rights lapsing and being forfeited under the
Plan; and (b) 5:00 pm (WST) on 12 November 2031 (Expiry Date). For the avoidance of doubt, any unconverted Performance Rights will
automatically lapse on the Expiry Date. - Vesting Conditions
Unless otherwise determined by the Board in accordance with the Plan, the
Performance Rights will vest on the date which is three (3) years after the
date of grant (Vesting Date), subject to the Related Party remaining an
officeholder, or employed or engaged by the Company at the Vesting Date (Vesting Condition).
Rights attaching to
Performance Rights
Prior to a Performance Right being converted, the holder:
(a) does not have any interest (legal, equitable or otherwise) in any
Share which may be issued on conversion of the Performance
Right other than as expressly set out in the Plan;
(b) is not entitled to receive notice of, vote at or attend a meeting of
the shareholders of the Company;
(c) is not entitled to receive any dividends declared by the Company;
and
(d) is not entitled to participate in any new issue of Shares (refer to
section 16).
7. Restrictions on
dealing with
Performance Rights
The Performance Rights cannot be sold, assigned, transferred, have a
security interest granted over or otherwise dealt with unless in Special
Circumstances under the Plan (including in the case of death or total or
permanent disability of the holder) with the consent of the Board.
A holder must not enter into any arrangement for the purpose of hedging
their economic exposure to a Performance Right that has been granted to
them.
8.
Cessation of
Employment
Any unvested Performance Rights will automatically be forfeited on the
termination or cessation of the Participant’s employment for any reason.
9.
Forfeiture
Conditions
Performance Rights will be forfeited in the following circumstances:
(a) in the case of unvested Performance Rights only, where a
Participant who holds Performance Rights ceases to be an Eligible
Participant (e.g. is no longer employed or their office or
engagement is discontinued with the Company and any
Associated Bodies Corporate (as defined in the Corporations Act)
(the Group);
16
(b) where a Participant acts fraudulently, dishonestly, negligently, in
contravention of any Group policy or wilfully breaches their duties
to the Group and the Board exercises its discretion to deem some
or all of the Performance Rights held by a Participant to have been
forfeited;
(c) where there is a failure to satisfy the vesting conditions in
accordance with the Plan;
(d) on the date the Participant becomes insolvent; or
(e) on the expiry date of the Performance Rights.
10. Conversion The Performance Rights can be converted at any time on and from the
delivery of a vesting notice until the Expiry Date (Conversion Period).
11. Conversion Notice
The Performance Rights may be converted during the Conversion Period by
delivery of a written notice specifying the number of Performance Rights
being converted (Conversion Notice).
12. Timing of issue of
Shares and
quotation of Shares
on conversion
Within five Business Days after the issue of a Conversion Notice by the
holder, the Company will:
(a) issue, allocate or cause to be transferred to the holder the number
of Shares to which the holder is entitled; and
(b) if required, issue a substitute certificate for any remaining
unconverted Performance Rights held by the holder.
Additionally, the Company will do all such acts, matters and things to obtain
the grant of quotation of the Shares by ASX in accordance with the ASX
Listing Rules and subject to the expiry of any restriction period that applies
to the Shares under the Corporations Act or the ASX Listing Rules, as soon
as reasonably practicable.
13.
Restrictions on
transfer of Shares
on conversion
Shares issued on conversion of the Performance Rights are subject to the
following restrictions:
(a) if the Company is required but is unable to give ASX a notice that
complies with section 708A(5)(e) of the Corporations Act, Shares
issued on conversion of the Performance Rights may not be
traded until 12 months after their issue unless the Company, at its
sole discretion, elects to issue a prospectus pursuant to
section 708A(11) of the Corporations Act;
(b) all Shares issued on conversion of the Performance Rights are
subject to restrictions imposed by Applicable Law on dealing in
Shares by persons who possess material information likely to
affect the value of the Shares and which is not generally available;
and
(c) all Shares issued on conversion of the Performance Rights are
subject to the terms of the Company’s Securities Trading Policy as
set out on the Company’s website.
14. Rights attaching to
Shares on
conversion
Shares issued upon conversion of the Performance Rights will rank equally
with the then Shares of the Company.
15. Change of Control If a change of control event occurs (being an event which results in any
person (either alone or together with associates) owning more than 50% of
the Company’s issued capital), unvested Performance Rights will vest unless
the Board determines in its discretion otherwise. The Board’s discretion in
determining the treatment of any unvested Performance Rights on a change
of control event is limited to vesting or varying any vesting conditions in
17
respect to the Performance Rights and does not include a discretion to lapse
or forfeit unvested Performance Rights for less than fair value.
16.
Participation in
new issues
Subject always to the rights under paragraphs 17 and 18, holders of
Performance Rights will not be entitled to participate in new issues of capital
offered to holders of Shares such as bonus issues and entitlement issues.
17.
Adjustment for
bonus issue
If Shares are issued by the Company by way of bonus issue (other than an
issue in lieu of dividends or by way of dividend reinvestment), the holder of
Performance Rights is entitled, upon conversion of the Performance Rights,
to receive an issue of as many additional Shares as would have been issued
to the holder if the holder held Shares equal in number to the Shares in
respect of which the Performance Rights are converted.
18. Reorganisation If there is a reorganisation of the issued share capital of the Company
(including any subdivision, consolidation, reduction, return or cancellation
of such issued capital of the Company), the rights of each holder holding
Performance Rights will be changed to the extent necessary to comply with
the ASX Listing Rules applicable to a reorganisation of capital at the time of
the reorganisation.
19. Buy-Back
Subject to applicable law, the Company may at any time buy-back the
Performance Rights in accordance with the terms of the Plan.
20. Employee Share
Trust
The Board uses an employee share trust for the purposes of holding
Performance Rights for holders under the Plan and delivering Shares on
behalf of holders upon conversion of Performance Rights. Further details of
the Employee Share Trust are set out in the Invitation.
18
SCHEDULE 2 – TERMS AND CONDITIONS OF PLAN
A summary of the material terms of the Company’s Employee Incentive Performance Rights Plan (Plan) is set
out below.
Eligible Participant
Eligible Participant means a person that is a ‘primary participant’ (as that term
is defined in Division 1A of Part 7.12 of the Corporations Act) in relation to the
Company or an Associated Body Corporate (as defined in the Corporations Act)
and has been determined by the Board to be eligible to participate in the Plan
from time to time.
Purpose The purpose of the Plan is to:
(a) assist in the reward, retention and motivation of Eligible Participants;
(b) link the reward of Eligible Participants to Shareholder value creation;
and
(c) align the interests of Eligible Participants with shareholders of the
Group (being the Company and each of its Associated Bodies
Corporate), by providing an opportunity to Eligible Participants to
receive an equity interest in the Company in the form of performance
rights (Performance Rights).
Maximum number of
Performance Rights
The Company will not make an invitation under the Plan which involves monetary
consideration if the number of Shares that may be issued, or acquired upon
exercise of Performance Rights offered under an invitation, when aggregated
with the number of Shares issued or that may be issued as a result of all
invitations under the Plan during the 3 year period ending on the day of the
invitation, will exceed 5% of the total number of issued Shares at the date of the
invitation (unless the Constitution specifies a different percentage and subject
to any limits approved by Shareholders under Listing Rule 7.2 Exception 13(b)).
Plan administration
The Plan will be administered by the Board. The Board may exercise any power
or discretion conferred on it by the Plan rules in its sole and absolute discretion
(except to the extent that it prevents the Participant relying on the deferred tax
concessions under Subdivision 83A-C of the Income Tax Assessment Act
1997 (Cth)). The Board may delegate its powers and discretion.
Eligibility, invitation
and application
The Board may from time to time determine that an Eligible Participant may
participate in the Plan and make an invitation to that Eligible Participant to apply
for Performance Rights provided under the Plan on such terms and conditions
as the Board decides.
On receipt of an invitation, an Eligible Participant may apply for the Performance
Rights the subject of the invitation by sending a completed application form to
the Company. The Board may accept an application from an Eligible Participant
in whole or in part.
If an Eligible Participant is permitted in the invitation, the Eligible Participant
may, by notice in writing to the Board, nominate a party in whose favour the
Eligible Participant wishes to renounce the invitation.
Grant of Performance
Rights
The Company will, to the extent that it has accepted a duly completed
application, grant the Participant the relevant number and type of Performance
Rights, subject to the terms and conditions set out in the invitation, the Plan rules
and any ancillary documentation required.
Rights attaching to
Performance Rights
Prior to a Performance Right being exercised, the holder:
19
(a) does not have any interest (legal, equitable or otherwise) in any Share
the subject of the Performance Right other than as expressly set out
in the Plan;
(b) is not entitled to receive notice of, vote at or attend a meeting of the
shareholders of the Company;
(c) is not entitled to receive any dividends declared by the Company; and
(d) is not entitled to participate in any new issue of Shares (see
Adjustment of Performance Rights section below).
Restrictions on
dealing with
Performance Rights
Performance Rights issued under the Plan cannot be sold, assigned, transferred,
have a security interest granted over or otherwise dealt with unless in Special
Circumstances as defined under the Plan (including in the case of death or total
or permanent disability of the holder) with the consent of the Board in which
case the Performance Rights may be exercisable on terms determined by the
Board.
A holder must not enter into any arrangement for the purpose of hedging their
economic exposure to a Performance Right that has been granted to them.
Vesting of
Performance Rights
Any vesting conditions applicable to the Performance Rights will be described
in the invitation. If all the vesting conditions are satisfied and/or otherwise
waived by the Board, a vesting notice will be sent to the Participant by the
Company informing them that the relevant Performance Rights have vested.
Unless and until the vesting notice is issued by the Company, the Performance
Rights will not be considered to have vested. For the avoidance of doubt, if the
vesting conditions relevant to a Performance Right are not satisfied and/or
otherwise waived by the Board, that security will lapse.
Exercise of
Performance Rights
To exercise a Performance Right, the Participant must deliver a signed notice of
exercise at any time following vesting of the Performance Right (if subject to
vesting conditions) and prior to the expiry date as set out in the invitation or
vesting notice.
A Performance Right may not be exercised unless and until that security has
vested in accordance with the Plan rules, or such earlier date as set out in the
Plan rules.
Timing of issue of
Shares and quotation
of Shares on exercise
As soon as practicable after the valid exercise of a Performance Right by a
Participant, the Company will issue or cause to be transferred to that Participant
the number of Shares to which the Participant is entitled under the Plan rules
and issue a substitute certificate for any remaining unexercised Performance
Rights held by that Participant.
Forfeiture of
Performance Rights
Performance Rights will be forfeited in the following circumstances:
(a) where a Participant who holds Performance Rights ceases to be an
Eligible Participant (e.g. is no longer employed or their office or
engagement is discontinued with the Group), all unvested
Performance Rights will automatically be forfeited by the Participant;
(b) where a Participant acts fraudulently or dishonestly, negligently, in
contravention of any Group policy or wilfully breaches their duties to
the Group;
(c) where there is a failure to satisfy the vesting conditions in accordance
with the Plan;
(d) on the date the Participant becomes insolvent; or
(e) on the expiry date of the Performance Rights.
20
Restriction periods
and restrictions on
transfer of Shares on
exercise
If the invitation provides that any Shares issued upon the valid exercise of a
Performance Right are subject to any restrictions as to the disposal or other
dealing by a Participant for a period, the Board may implement any procedure
it deems appropriate to ensure the compliance by the Participant with this
restriction.
Additionally, Shares issued on exercise of the Performance Rights are subject to
the following restrictions:
(a) if the Company is required but is unable to give ASX a notice that
complies with section 708A(5)(e) of the Corporations Act, Shares
issued on exercise of the Performance Rights may not be traded
until 12 months after their issue unless the Company, at its sole
discretion, elects to issue a prospectus pursuant to section 708A(11)
of the Corporations Act;
(b) all Shares issued on exercise of Performance Rights are subject to
restrictions imposed by applicable law on dealing in Shares by
persons who possess material information likely to affect the value of
the Shares and which is not generally available; and
(c) all Shares issued on exercise of the Performance Rights are subject to
the terms of the Company’s Securities Trading Policy.
Rights attaching to
Shares on exercise
All Shares issued upon exercise of Performance Rights will rank equally in all
respects with the then Shares of the Company.
A Participant will be entitled to any dividends declared and distributed by the
Company on the Shares issued upon exercise of a Performance Right and may
participate in any dividend reinvestment plan operated by the Company in
respect of Shares. A Participant may exercise any voting rights attaching to
Shares issued under the Plan.
Change of control If a change of control event occurs (being an event which results in any person
(either alone or together with associates) owning more than 50% of the
Company’s issued capital), unvested Performance Rights will vest unless the
Board determines in its discretion otherwise. The Board’s discretion in
determining the treatment of any unvested Performance Rights on a change of
control event is limited to vesting or varying any vesting conditions in respect
to the Performance Rights and does not include a discretion to lapse or forfeit
unvested Performance Rights for less than fair value.
Participation in
entitlements and
bonus issues
Subject always to the rights under the following two paragraphs, Participants
will not be entitled to participate in new issues of capital offered to holders of
Shares such as bonus issues and entitlement issues.
Adjustment for bonus
issue
If Shares are issued by the Company by way of bonus issue (other than an issue
in lieu of dividends or by way of dividend reinvestment), the Participant is
entitled, upon exercise of the Performance Rights, to receive an issue of as many
additional Shares as would have been issued to the holder if the holder held
Shares equal in number to the Shares in respect of which the Performance
Rights are exercised.
Reorganisation
If there is a reorganisation of the issued share capital of the Company (including
any subdivision, consolidation, reduction, return or cancellation of such issued
capital of the Company), the rights of each Participant holding Performance
Rights will be changed to the extent necessary to comply with the ASX Listing
Rules applicable to a reorganisation of capital at the time of the reorganisation.
Buy-Back
Subject to applicable law, the Company may at any time buy-back Performance
Rights and Shares issued upon exercise of Performance Rights in accordance
with the terms of the Plan.
21
Employee Share Trust The Board may in its sole and absolute discretion use an employee share trust
or other mechanism for the purposes of holding Performance Rights for holders
under the Plan and delivering Shares on behalf of holders upon exercise of
Performance Rights.
Amendment of Plan Subject to the following paragraph, the Board may at any time amend any
provisions of the Plan rules, including (without limitation) the terms and
conditions upon which any Performance Rights have been granted under the
Plan and determine that any amendments to the Plan rules be given
retrospective effect, immediate effect or future effect.
No amendment to any provision of the Plan rules may be made if the
amendment materially reduces the rights of any Participant as they existed
before the date of the amendment, other than an amendment introduced
primarily for the purpose of complying with legislation or to correct manifest
error or mistake, amongst other things, or is agreed to in writing by all
Participants.
Plan duration The Plan continues in operation until the Board decides to end it. The Board
may from time to time suspend the operation of the Plan for a fixed period or
indefinitely and may end any suspension. If the Plan is terminated or suspended
for any reason, that termination or suspension must not prejudice the accrued
rights of the Participants.
If a Participant and the Company (acting by the Board) agree in writing that some
or all of the Performance Rights granted to that Participant are to be cancelled
on a specified date or on the occurrence of a particular event, then those
Performance Rights may be cancelled in the manner agreed between the
Company and the Participant.
Income Tax
Assessment Act
The Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act
1997 (Cth) applies (subject to the conditions in that Act) except to the extent an
invitation provides otherwise.
SRN/HIN: LYCOPODIUM LIMITED ABN 83 098 556 159 For your proxy appointment to be effective it must be received by 10.30am (AWST) on Tuesday, 10 November 2026. All your securities will be voted in accordance with your directions. YOUR VOTE IS IMPORTANT Phone: 1300 764 130 (within Australia) +61 (3) 9415 4267 (outside Australia) Online: www.investorcentre.com/contact Need assistance? Proxy Form Lodge your Proxy Form:How to Vote on Items of Business Online: Lodge your vote online at www.investorvote.com.au using your secure access information or use your mobile device to scan the personalised QR code. Corporate Representative If a representative of a corporate securityholder or proxy is to participate in the meeting you will need to provide the appropriate “Appointment of Corporate Representative”. A form may be obtained from Computershare or online at www.investorcentre.com/au and select "Printable Forms". PARTICIPATING IN THE MEETING SIGNING INSTRUCTIONS FOR POSTAL FORMS For Intermediary Online subscribers (custodians) go to www.intermediaryonline.com By Mail: Computershare Investor Services Pty Limited GPO Box 242 Melbourne VIC 3001 Australia 1800 783 447 within Australia or +61 3 9473 2555 outside Australia By Fax: Your secure access information is APPOINTMENT OF PROXY PLEASE NOTE: For security reasons it is important that you keep your SRN/HIN confidential. Control Number: 189130 Individual: Where the holding is in one name, the securityholder must sign. Joint Holding: Where the holding is in more than one name, all of the securityholders should sign. Power of Attorney: If you have not already lodged the Power of Attorney with the registry, please attach a certified photocopy of the Power of Attorney to this form when you return it. Companies: Where the company has a Sole Director who is also the Sole Company Secretary, this form must be signed by that person. If the company (pursuant to section 204A of the Corporations Act 2001) does not have a Company Secretary, a Sole Director can also sign alone. Otherwise this form must be signed by a Director jointly with either another Director or a Company Secretary. Please sign in the appropriate place to indicate the office held. Delete titles as applicable. Voting 100% of your holding: Direct your proxy how to vote by marking one of the boxes opposite each item of business. If you do not mark a box your proxy may vote or abstain as they choose (to the extent permitted by law). If you mark more than one box on an item your vote will be invalid on that item. Voting a portion of your holding: Indicate a portion of your voting rights by inserting the percentage or number of securities you wish to vote in the For, Against or Abstain box or boxes. The sum of the votes cast must not exceed your voting entitlement or 100%. Appointing a second proxy: You are entitled to appoint up to two proxies to attend the meeting and vote on a poll. If you appoint two proxies you must specify the percentage of votes or number of securities for each proxy, otherwise each proxy may exercise half of the votes. When appointing a second proxy write both names and the percentage of votes or number of securities for each in Step 1 overleaf. A proxy need not be a securityholder of the Company. You may elect to receive meeting-related documents, or request a particular one, in electronic or physical form and may elect not to receive annual reports. To do so,
604 page 1/2 15 July 2018 AUSTRALIA 1103581615v1 Form 604 Corporations Act 2001 Section 671B Notice of change of interests of substantial holder To Company/registered scheme/notified foreign passport fund name Lycopodium Limited ACN/ARSN/APFRN 098 556 159 NFPFRN (if applicable)
- Details of substantial holder (1) Name Braeside Investments, LLC ("Braeside") on behalf of itself and the persons listed in Annexure A. ACN/ARSN/APFRN (if applicable) NFPFRN (if applicable) There was a change in the interests of the substantial holder on 05/10/2026 The previous notice was given to the company, or the responsible entity for a registered scheme, or the operator of a notified foreign passport fund on 10/01/2024 The previous notice was dated 10/01/2024
- Previous and present voting power The total number of votes attached to all the voting shares or interests in the company, scheme or fund that the substantial holder or an associate (2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company, scheme or fund, are as follows: Class of securities (4) Previous notice Present notice Person’s votes Voting power (5) Person’s votes Voting power (5) ORD 2,636,410 6.634% 2,200,344 5.537%
- Changes in relevant interests Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company, scheme or fund, since the substantial holder was last required to give a substantial holding notice to the company, scheme or fund are as follows: Date of change
Person whose relevant interest
changed Nature of change (6)
Consideration given in relation
to change (7) Class and number of
securities affected Person’s votes affected
- Present relevant interests Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows: Holder of relevant
interest Registered holder of
securities Person entitled to be registered
as holder (8) Nature of relevant
interest (6) Class and number of
securities Person’s votes 6HH$QQH[XUH$ 6HH$QQH[XUH% 1
604 page 2/2 15 July 2018
AUSTRALIA 1103581615v1
5. Changes in association
The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in
relation to voting securities in the company, scheme or fund are as follows:
Name and ACN/ARSN/APFRN (if
applicable)
and NFPFRN (if
applicable)
Nature of association
Antaeus Holdings, Ltd.
Associate pursuant to section 12(2)(c) of the Corporations Act 2001 (Cth) as it is acting in
concert with Braeside Investments, LLC in relation to the affairs of Lycopodium Limited
Prelude Structured Alternatives Master
Fund, LP.
Ceased KROGLQJ securities in Lycopodium Limited RQ 5 6HSWHPEHU 05
6. Addresses
The addresses of persons named in this form are as follows:
Name Address
Signature
print name capacity
sign here date / /
DIRECTIONS
(1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and
trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar,
they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and
addresses of members
is clearly set out in paragraph 6 of the form.
(2) See the definition of "associate" in section 9 of the Corporations Act 2001.
(3) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.
(4) The voting shares of a company constitute one class unless divided into separate classes.
(5) The person’s votes divided by the total votes in the body corporate, scheme or fund multiplied by 100.
(6) Include details of:
(a)any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy
of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract,
scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrang
ement; and
(b)any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the
securities to which the relevant interest relates (indicating clearly the particular securities to which the
qualification applies).
See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.
(7) Details of the consideration must include any and all benefits, money or otherwise, that any person from whom a relevant interest was acquired has, or
may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional
on the happening or not of a
contingency. Details must be in
cluded of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they
are not paid directly to the person from whom the relevant interest was acquired.
(8) If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write “unknown’”.
(9) Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.
6HH$QQH[XUH%
2
Todd Stein
manager
7 10 26
604 GUIDE page 1/1 15 July 2018 AUSTRALIA 1103581615v1 GUIDE This guide does not form part of the prescribed form and is included by ASIC to assist you in completing and lodging form 604. Signature Company - form must be signed by a director or secretary. Foreign company - form may be signed by the local agent, or if the local agent is a company, a director or secretary of the company.
Registered scheme - form must be signed by director or secretary of the responsible entity. Lodging period Nil Lodging Fee Nil Other forms to be completed
Nil Additional information (a) If additional space is required to complete a question, the information may be included on a separate piece of paper annexed to the form. (b) This notice must be given to a listed company, or the responsible entity for a registered scheme, or the operator of a notified foreign passport fund. A copy of this notice must also be given to each relevant securities exchange. (c) The person must give a copy of this notice: (i)within 2 business days after they become aware of the information; or (ii) by 9.30 am on the next trading day of the relevant securities exchange after they become aware of th e inf ormation if: (A) a takeover bid is made for voting shares or interests in the company or registered scheme; and (B) the person becomes aware of the information during the bid period . Annexures To make any annexure conform to the regulations, you must 1 use A4 size paper of white or light pastel colour with a margin of at least 10mm on all sides 2 show the corporation/registered scheme/notified foreign passport fund name and ACN/ARBN/ARSN and APFRN (if applicable) and NFPFRN (if applicable) 3 number the pages consecutively 4 print or type in BLOCK letters in dark blue or black ink so that the document is clearly legible when photocopied 5 identify the annexure with a mark such as A, B, C, etc 6 endorse the annexure with the words: This is annexure (mark) of (number) pages referred to in form (form number and title) 7 sign and date the annexure. The annexure must be signed by the same person(s) who signed the form. Information in this guide is intended as a guide only. Please consult your accountant or solicitor for further advice. 3
Annexure A This is Annexure A of pages referred to in Form 604 .................................................................................. Todd Stein, Manager Date: 4 7/10/2026
Date of change Person whose relevant interest changedNature of change Consideration given in relation to change (AUD) Class and number of securities affected - Ordinary SharesPerson's votes affected 9/01/2024Braeside Capital, L.P.Sales on the ASX(36,810.22)$ (3,063) Braeside Capital, L.P. 9/01/2024Braeside Capital II, L.P.Sales on the ASX(44,669.79)$ (3,717) Braeside Capital II, L.P. 10/01/2024Braeside Capital, L.P.Sales on the ASX(19,112.25)$ (1,586) Braeside Capital, L.P. 10/01/2024Braeside Capital II, L.P.Sales on the ASX(17,063.65)$ (1,416) Braeside Capital II, L.P. 11/01/2024Braeside Capital, L.P.Sales on the ASX(52,276.04)$ (4,331) Braeside Capital, L.P. 11/01/2024Braeside Capital II, L.P.Sales on the ASX(59,083.63)$ (4,895) Braeside Capital II, L.P. 12/01/2024Braeside Capital, L.P.Sales on the ASX(40,887.41)$ (3,376) Braeside Capital, L.P. 12/01/2024Braeside Capital II, L.P.Sales on the ASX(45,744.00)$ (3,777) Braeside Capital II, L.P. 24/01/2024Braeside Capital, L.P.Sales on the ASX(49,416.46)$ (4,296) Braeside Capital, L.P. 24/01/2024Braeside Capital II, L.P.Sales on the ASX(45,919.58)$ (3,992) Braeside Capital II, L.P. 25/01/2024Braeside Capital, L.P.Sales on the ASX(61,139.91)$ (5,334) Braeside Capital, L.P. 25/01/2024Braeside Capital II, L.P.Sales on the ASX(77,210.05)$ (6,736) Braeside Capital II, L.P. 1/02/2024Braeside Capital, L.P.Sales on the ASX(73,832.56)$ (6,027) Braeside Capital, L.P. 1/02/2024Braeside Capital II, L.P.Sales on the ASX(61,582.26)$ (5,027) Braeside Capital II, L.P. 2/02/2024Braeside Capital, L.P.Sales on the ASX(32,257.10)$ (2,651) Braeside Capital, L.P. 2/02/2024Braeside Capital II, L.P.Sales on the ASX(36,540.20)$ (3,003) Braeside Capital II, L.P. 5/02/2024Braeside Capital, L.P.Sales on the ASX(81,366.35)$ (6,631) Braeside Capital, L.P. 5/02/2024Braeside Capital II, L.P.Sales on the ASX(89,329.97)$ (7,280) Braeside Capital II, L.P. 8/02/2024Braeside Capital, L.P.Sales on the ASX(81,512.34)$ (6,678) Braeside Capital, L.P. 8/02/2024Braeside Capital II, L.P.Sales on the ASX(87,859.51)$ (7,198) Braeside Capital II, L.P. 9/02/2024Braeside Capital, L.P.Sales on the ASX(47,466.86)$ (3,934) Braeside Capital, L.P. 9/02/2024Braeside Capital II, L.P.Sales on the ASX(51,581.30)$ (4,275) Braeside Capital II, L.P. 12/02/2024Braeside Capital, L.P.Sales on the ASX(41,121.36)$ (3,360) Braeside Capital, L.P. 12/02/2024Braeside Capital II, L.P.Sales on the ASX(43,324.29)$ (3,540) Braeside Capital II, L.P. 16/02/2024Braeside Capital, L.P.Sales on the ASX(60,302.33)$ (5,017) Braeside Capital, L.P. 16/02/2024Braeside Capital II, L.P.Sales on the ASX(65,987.60)$ (5,490) Braeside Capital II, L.P. 20/02/2024Braeside Capital, L.P.Sales on the ASX(40,318.67)$ (3,287) Braeside Capital, L.P. 20/02/2024Braeside Capital II, L.P.Sales on the ASX(46,353.59)$ (3,779) Braeside Capital II, L.P. 21/02/2024Braeside Capital, L.P.Sales on the ASX(30,580.48)$ (2,284) Braeside Capital, L.P. 21/02/2024Braeside Capital II, L.P.Sales on the ASX(36,163.69)$ (2,701) Braeside Capital II, L.P. 8/03/2024Braeside Capital, L.P.Sales on the ASX(85,918.60) $ (6,698) Braeside Capital, L.P. 8/03/2024Braeside Capital II, L.P.Sales on the ASX(56,466.66) $ (4,402)
Braeside Capital II, L.P. 11/03/2024Braeside Capital, L.P.Sales on the ASX(53,123.33)$ (4,165) Braeside Capital, L.P. 11/03/2024Braeside Capital II, L.P.Sales on the ASX(61,107.77)$ (4,791) Braeside Capital II, L.P. 8/05/2024Braeside Capital, L.P.Sales on the ASX(131,034.90)$ (9,999) Braeside Capital, L.P. 7/06/2024Antaeus Holdings, Ltd.Purchases on the ASX32,496.65$ 2,715 Antaeus Holdings, Ltd. 11/06/2024Antaeus Holdings, Ltd.Purchases on the ASX58,164.00$ 4,847 Antaeus Holdings, Ltd. 12/06/2024Antaeus Holdings, Ltd.Purchases on the ASX147,917.67$ 12,438 Antaeus Holdings, Ltd. 13/06/2024Antaeus Holdings, Ltd.Purchases on the ASX156,621.37$ 13,165 Antaeus Holdings, Ltd. 14/06/2024Antaeus Holdings, Ltd.Purchases on the ASX4,569.60$ 384 Antaeus Holdings, Ltd. 17/06/2024Antaeus Holdings, Ltd.Purchases on the ASX135,342.80$ 11,451 Antaeus Holdings, Ltd. 10/07/2024Braeside Capital, L.P.Sales on the ASX(3,209.90)$ (240) Braeside Capital, L.P. 18/07/2024Braeside Capital, L.P.Sales on the ASX(28,518.00)$ (2,100) Braeside Capital, L.P. 23/07/2024Braeside Capital, L.P.Sales on the ASX(41,226.98)$ (3,000) Braeside Capital, L.P. 25/07/2024Braeside Capital, L.P.Sales on the ASX(119,064.17)$ (8,639) Braeside Capital, L.P. 25/07/2024Braeside Capital II, L.P.Sales on the ASX(128,948.98)$ (9,361) Braeside Capital II, L.P. 26/07/2024Braeside Capital II, L.P.Sales on the ASX(71,100.00)$ (5,000) Braeside Capital II, L.P. 16/08/2024Braeside Capital, L.P.Sales on the ASX(58,981.19)$ (4,191) Braeside Capital, L.P. 16/08/2024Braeside Capital II, L.P.Sales on the ASX(67,678.49)$ (4,809) Braeside Capital II, L.P. 21/08/2024Antaeus Holdings, Ltd.Purchases on the ASX18,750.31$ 1,531 Antaeus Holdings, Ltd. 22/08/2024Antaeus Holdings, Ltd.Purchases on the ASX226,123.35$ 18,469 Antaeus Holdings, Ltd. 23/08/2024Antaeus Holdings, Ltd.Purchases on the ASX51,428.91$ 4,255 Antaeus Holdings, Ltd. 26/08/2024Antaeus Holdings, Ltd.Purchases on the ASX59,048.00$ 4,880 Antaeus Holdings, Ltd. 28/08/2024Antaeus Holdings, Ltd.Purchases on the ASX131,466.50$ 10,865 Antaeus Holdings, Ltd. 4/09/2024Antaeus Holdings, Ltd.Purchases on the ASX35,847.11$ 2,990 Antaeus Holdings, Ltd. 5/09/2024Antaeus Holdings, Ltd.Purchases on the ASX142,937.02$ 12,010 Antaeus Holdings, Ltd. 25/10/2024Antaeus Holdings, Ltd.Purchases on the ASX216,687.81$ 19,681 Antaeus Holdings, Ltd. 28/10/2024Antaeus Holdings, Ltd.Purchases on the ASX113,612.19$ 10,319 Antaeus Holdings, Ltd. 12/11/2024Antaeus Holdings, Ltd.Purchases on the ASX211,400.00$ 20,000 Antaeus Holdings, Ltd. 6/01/2025Braeside Capital II, L.P.Purchases on the ASX248,878.66$ 24,426 Braeside Capital II, L.P. 7/01/2025Braeside Capital II, L.P.Purchases on the ASX33,492.06$ 3,249 Braeside Capital II, L.P. 8/01/2025Braeside Capital II, L.P.Purchases on the ASX143,102.13$ 13,656 Braeside Capital II, L.P. 9/01/2025Braeside Capital II, L.P.Purchases on the ASX83,299.98$ 7,876 Braeside Capital II, L.P. 12/03/2025Antaeus Holdings, Ltd.Purchases on the ASX99,500.00$ 10,000 Antaeus Holdings, Ltd. 13/03/2025Antaeus Holdings, Ltd.Purchases on the ASX21,725.01$ 2,195 Antaeus Holdings, Ltd. 7/04/2025Antaeus Holdings, Ltd.Purchases on the ASX76,489.00$ 7,805 Antaeus Holdings, Ltd. 27/06/2025Braeside Capital, L.P.Purchases on the ASX80,528.55$ 7,764 Braeside Capital, L.P. 30/06/2025Braeside Capital, L.P.Purchases on the ASX235,005.18$ 22,650 Braeside Capital, L.P. 1/07/2025Braeside Capital, L.P.Purchases on the ASX199,775.86$ 19,293 Braeside Capital, L.P. 5 $
18/08/2025 Prelude Structured Alternatives Master Fund, LP Sales on the ASX(75,098.87)$ (6,173) Prelude Structured Alternatives Master Fund, LP 19/08/2025 Prelude Structured Alternatives Master Fund, LP Sales on the ASX(102,800.57)$ (8,414) Prelude Structured Alternatives Master Fund, LP 20/08/2025 Prelude Structured Alternatives Master Fund, LP Sales on the ASX(146,570.62) $ (11,967) Prelude Structured Alternatives Master Fund, LP 21/08/2025 Prelude Structured Alternatives Master Fund, LP Sales on the ASX(158,380.76) $ (13,012) Prelude Structured Alternatives Master Fund, LP 1/09/2025 Prelude Structured Alternatives Master Fund, LP Sales on the ASX(262.90) $ (22) Prelude Structured Alternatives Master Fund, LP 2/09/2025 Prelude Structured Alternatives Master Fund, LP Sales on the ASX(184,354.16) $ (15,384) Prelude Structured Alternatives Master Fund, LP 3/09/2025 Prelude Structured Alternatives Master Fund, LP Sales on the ASX(157,788.74) $ (12,994) Prelude Structured Alternatives Master Fund, LP 4/09/2025 Prelude Structured Alternatives Master Fund, LP Sales on the ASX(75,939.16) $ (6,247) Prelude Structured Alternatives Master Fund, LP 5/09/2025 Prelude Structured Alternatives Master Fund, LP Sales on the ASX(107,261.68) $ (8,686) Prelude Structured Alternatives Master Fund, LP 28/11/2025Antaeus Holdings, Ltd.Purchases on the ASX15,095.56 $ 1,202 Antaeus Holdings, Ltd. 1/12/2025Antaeus Holdings, Ltd.Purchases on the ASX11,440.80 $ 908 Antaeus Holdings, Ltd. 9/12/2025Antaeus Holdings, Ltd.Purchases on the ASX51,131.36 $ 3,976 Antaeus Holdings, Ltd. 10/12/2025Antaeus Holdings, Ltd.Purchases on the ASX27,404.66 $ 2,131 Antaeus Holdings, Ltd. 2/01/2026Braeside Capital, L.P.Purchases on the ASX210,368.93 $ 15,016 Braeside Capital, L.P. 5/01/2026Braeside Capital, L.P.Purchases on the ASX235,721.66 $ 16,706 Braeside Capital, L.P. 8/01/2026Braeside Capital II, L.P.Sales on the ASX(121,752.37) $ (8,299) Braeside Capital II, L.P. 9/01/2026Braeside Capital II, L.P.Sales on the ASX(101,368.53) $ (6,895) Braeside Capital II, L.P. 12/01/2026Braeside Capital II, L.P.Sales on the ASX(189,283.14) $ (13,000) Braeside Capital II, L.P. 13/01/2026Braeside Capital II, L.P.Sales on the ASX(213,475.08) $ (14,532) Braeside Capital II, L.P. 14/01/2026 Braeside Capital II, L.P.Sales on the ASX(389,933.86)$ (26,646) Braeside Capital II, L.P. 18/02/2026Antaeus Holdings, Ltd.Purchases on the ASX216,726.16$ 15,258 Antaeus Holdings, Ltd. 23/02/2026Antaeus Holdings, Ltd.Purchases on the ASX54,663.00$ 3,836 Antaeus Holdings, Ltd. 24/02/2026Antaeus Holdings, Ltd.Purchases on the ASX34,955.25$ 2,453 Antaeus Holdings, Ltd. 25/02/2026Antaeus Holdings, Ltd.Purchases on the ASX250,100.17$ 17,570 Antaeus Holdings, Ltd. 26/02/2026Antaeus Holdings, Ltd.Purchases on the ASX74,256.75$ 5,211 Antaeus Holdings, Ltd. 27/02/2026Antaeus Holdings, Ltd.Purchases on the ASX21,360.75$ 1,499 Antaeus Holdings, Ltd. 2/03/2026Antaeus Holdings, Ltd.Purchases on the ASX625,377.79$ 43,876 Antaeus Holdings, Ltd. 3/03/2026Antaeus Holdings, Ltd.Purchases on the ASX709,740.00$ 50,000 Antaeus Holdings, Ltd. 4/03/2026Antaeus Holdings, Ltd.Purchases on the ASX693,440.00$ 50,000 Antaeus Holdings, Ltd. 5/03/2026Antaeus Holdings, Ltd.Purchases on the ASX392,743.12$ 28,261 Antaeus Holdings, Ltd. 6/03/2026Antaeus Holdings, Ltd.Purchases on the ASX300,289.50$ 21,739 Antaeus Holdings, Ltd. 9/03/2026Antaeus Holdings, Ltd.Purchases on the ASX32,540.19$ 2,519 Antaeus Holdings, Ltd. 23/03/2026Antaeus Holdings, Ltd.Purchases on the ASX253,629.95 $ 19,495 Antaeus Holdings, Ltd. 27/03/2026Antaeus Holdings, Ltd.Purchases on the ASX79,374.01 $ 6,101 Antaeus Holdings, Ltd. 30/03/2026Antaeus Holdings, Ltd.Purchases on the ASX224,590.23 $ 17,341 Antaeus Holdings, Ltd. 31/03/2026Antaeus Holdings, Ltd.Purchases on the ASX214,282.48 $ 16,653 Antaeus Holdings, Ltd. 13/04/2026Antaeus Holdings, Ltd.Purchases on the ASX173,543.03 $ 13,347 Antaeus Holdings, Ltd. 14/04/2026Antaeus Holdings, Ltd.Purchases on the ASX35,268.64 $ 2,764 Antaeus Holdings, Ltd. 17/04/2026Antaeus Holdings, Ltd.Purchases on the ASX35,957.68 $ 2,818 Antaeus Holdings, Ltd. 20/04/2026Antaeus Holdings, Ltd.Purchases on the ASX27,217.08 $ 2,133 Antaeus Holdings, Ltd. 22/04/2026Antaeus Holdings, Ltd.Purchases on the ASX7,541.16 $ 591 Antaeus Holdings, Ltd. 23/04/2026Antaeus Holdings, Ltd.Purchases on the ASX276,815.44 $ 21,694 Antaeus Holdings, Ltd. 19/05/2026Antaeus Holdings, Ltd.Purchases on the ASX60,895.80 $ 4,833 Antaeus Holdings, Ltd. 20/05/2026Antaeus Holdings, Ltd.Purchases on the ASX313,416.16 $ 24,882 Antaeus Holdings, Ltd. 21/05/2026Antaeus Holdings, Ltd.Purchases on the ASX7,760.80 $ 616 Antaeus Holdings, Ltd. 22/05/2026Antaeus Holdings, Ltd.Purchases on the ASX131,854.81 $ 10,465 Antaeus Holdings, Ltd. 3/06/2026Braeside Capital II, L.P.Sales on the ASX(77,174.00) $ (4,700) Braeside Capital II, L.P. 4/06/2026Braeside Capital II, L.P.Sales on the ASX(188,339.31) $ (11,453) Braeside Capital II, L.P. 16/06/2026Braeside Capital, L.P.Sales on the ASX(308,030.87) $ (17,555) Braeside Capital, L.P. 16/06/2026Braeside Capital II, L.P.Sales on the ASX(558,169.18) $ (31,812) Braeside Capital II, L.P. 17/06/2026Braeside Capital, L.P.Sales on the ASX(1,819,818.46) $ (102,854) Braeside Capital, L.P. 17/06/2026Braeside Capital II, L.P.Sales on the ASX(1,850,449.99) $ (104,585) Braeside Capital II, L.P. 18/06/2026Braeside Capital, L.P.Sales on the ASX(471,230.34) $ (26,002) Braeside Capital, L.P. 18/06/2026Braeside Capital II, L.P.Sales on the ASX(480,789.88) $ (26,529) Braeside Capital II, L.P. 19/06/2026Braeside Capital, L.P.Sales on the ASX(185,168.10) $ (10,235) Braeside Capital, L.P. 19/06/2026Braeside Capital II, L.P.Sales on the ASX(199,140.11) $ (11,007) Braeside Capital II, L.P. 22/06/2026Braeside Capital, L.P.Sales on the ASX(512,158.82) $ (27,608) Braeside Capital, L.P. 22/06/2026Braeside Capital II, L.P.Sales on the ASX(523,546.14) $ (28,220) Braeside Capital II, L.P. 23/06/2026Braeside Capital, L.P.Sales on the ASX(1,042,762.14) $ (55,499) Braeside Capital, L.P. 23/06/2026Braeside Capital II, L.P.Sales on the ASX(1,058,853.07) $ (56,355) Braeside Capital II, L.P. 7/08/2026Braeside Capital, L.P.Sales on the ASX(294,021.46) $ (15,073) Braeside Capital, L.P. 7/08/2026Braeside Capital II, L.P.Sales on the ASX(395,449.81) $ (20,277) Braeside Capital II, L.P. 19/08/2026Braeside Capital, L.P.Sales on the ASX(460,625.62) $ (22,012) Braeside Capital, L.P. 19/08/2026Braeside Capital II, L.P.Sales on the ASX(469,549.06) $ (22,438) Braeside Capital II, L.P. 6
20/08/2026Braeside Capital, L.P.Sales on the ASX(327,127.24)$ (15,506) Braeside Capital, L.P. 20/08/2026Braeside Capital II, L.P.Sales on the ASX(317,178.97)$ (15,035) Braeside Capital II, L.P. 21/08/2026Braeside Capital, L.P.Sales on the ASX(123,763.58)$ (5,696) Braeside Capital, L.P. 21/08/2026Braeside Capital II, L.P.Sales on the ASX(135,497.80)$ (6,236) Braeside Capital II, L.P. 24/08/2026Braeside Capital, L.P.Sales on the ASX(83,410.30)$ (3,795) Braeside Capital, L.P. 24/08/2026Braeside Capital II, L.P.Sales on the ASX(58,284.50)$ (2,652) Braeside Capital II, L.P. 1/09/2026Braeside Capital, L.P.Sales on the ASX(288,313.83)$ (12,753) Braeside Capital, L.P. 1/09/2026Braeside Capital II, L.P.Sales on the ASX(294,100.67)$ (13,009) Braeside Capital II, L.P. 2/09/2026Braeside Capital, L.P.Sales on the ASX(409,474.44)$ (18,140) Braeside Capital, L.P. 2/09/2026Braeside Capital II, L.P.Sales on the ASX(233,652.01)$ (10,361) Braeside Capital II, L.P. 23/09/2026Braeside Capital, L.P.Sales on the ASX(476,918.52)$ (20,694) Braeside Capital, L.P. 23/09/2026Braeside Capital II, L.P.Sales on the ASX(467,963.97)$ (20,306) Braeside Capital II, L.P. 5/10/2026Braeside Capital, L.P.Sales on the ASX(509,202.25)$ (21,000) Braeside Capital, L.P. 5/10/2026Braeside Capital II, L.P.Sales on the ASX(560,827.19)$ (23,130) Braeside Capital II, L.P. 7
Annexure B
This is Annexure B of 3 pages referred to in Form 604
..................................................................................
Todd Stein, Manager
Date:
8
7/10/2026
- Details of present registered holders
Holder of
relevant interest Registered holder of
securities Person entitled to be registered as
holder Nature of
Relevant Interest
Class and
number of
securities Person's votes Braeside Investments, LLC. as investment manager ,QWHUDFWLYH %URkHUV LLC Braeside Capital, L.P. Relevant interest in
securities pursuant to
section 608(1)
of the Corporations Act 2001 (Cth) by virtue of
being the
investment manager to
Braeside Capital, L.P. 0 ordinary shares 0 Braeside Investments, LLC. as investment manager ,QWHUDFWLYH %URkHUV LLC Braeside Capital II, L.P. Relevant interest in
securities pursuant to
section 608(1)
of the Corporations Act 2001 (Cth) by virtue of
being the
investment manager to
Braeside Capital II, L.P. 5 ordinary shares 5 Braeside Investments, LLC. as investment manager 86 %DQk$QWDHXV +ROGLQJV LWG Relevant interest in
securities pursuant to
section 608(1)
of the Corporations Act 2001 (Cth) by virtue of
being the
investment manager to
$QWDHXV +ROGLQJV LWG 5 ordinary shares 5 1 9 %
Holder of
relevant
interest
Registered
holder of
securities
Person
entitled to be
registered as
holder
Nature of
Relevant
Interest
Class and
number of
securities
Person's
votes
Braeside
Capital, L.P.
,QWHUDFWLYH
%URkHUV LLC
Braeside
Capital, L.P.
Relevant
interest in
securities
pursuant to
section 608(1)
of the
Corporations
Act 2001 (Cth)
by virtue of
being the
entity on
whose behalf
the securities
are held.
0
ordinary
shares
0
Braeside
Capital II, L.P.
,QWHUDFWLYH
%URkHUV LLC
Braeside
Capital II, L.P.
Relevant
interest in
securities
pursuant to
section 608(1)
of the
Corporations
Act 2001 (Cth)
by virtue of
being the
entity on
whose behalf
the securities
are held.
5
ordinary
shares
5
$QWDHXV
+ROGLQJV LWG
86 %DQk$QWDHXV
+ROGLQJV LWG
Relevant
interest in
securities
pursuant to
section 608(1)
of the
Corporations
Act 2001 (Cth)
by virtue of
being the
entity on
whose behalf
the securities
are held.
5
ordinary
shares
5
2
10
- Addresses
Name Address
Braeside
Investments, LLC.
14841DallasParkway,Suite415
Dallas, TX 75254
Braeside Capital,
L.P. 14841 DallasParkway,Suite415 Dallas, TX 75254 Braeside Capital
II, L.P. 14841DallasParkway,Suite415 Dallas, TX 75254 $QWDHXV +ROGLQJV LWG 3 11 DallasParkway,Suite 450 14841 Dallas, TX 75254
PERTH, 2 October 2026
Lycopodium Limited (ASX: LYL) (Company) advises that, in accordance with ASX Listing Rule 3.13.1
and clause 14.3 of its Constitution, its next Annual General Meeting (AGM) will be held at 10:30am
(AWST) on 12 November 2026.
In addition, the closing date for the receipt of nominations from persons wishing to be considered for
election as a director is 9 October 2026. Any nominations must be received in writing no later than
5.00pm (WST) on 9 October 2026 at the Company’s registered office.
Shareholders will be advised of further details regarding the AGM, including the date and time of the
AGM, in a separate Notice of Meeting, which will be available on the ASX Company Announcements
Platform and the Company’s website at
https://www.lycopodium.com/investor-relations/asx-
announcements/ on 9 October 2026.
Authorised by:
Justine Campbell Company Secretary
Appendix 3Y Change of Director’s Interest Notice
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1 Doc ID 691538253/v1 Rule 3.19A.2 Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11
Name of entity Lycopodium Limited ABN 83 098 556 159
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director Karl Cicanese Date of last notice 8 December 2025
Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Direct or indirect interest Direct Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change 2 October 2026 No. of securities held prior to change 17,203 fully paid ordinary shares 38,285 Class A Performance Rights Class Ordinary Shares Class A Performance Rights
Number acquired
Number disposed
17,003
Appendix 3Y Change of Director’s Interest Notice
- See chapter 19 for defined terms.
Appendix 3Y Page 2 01/01/2011 Doc ID 691538253/v1 Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation
$401,781 No. of securities held after change 200 Fully Paid Ordinary Shares 38,285 Class A Performance Rights Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back Sale of shares on market
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
Detail of contract N/A Nature of interest
N/A Name of registered holder (if issued securities)
N/A Date of change N/A No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
N/A Interest acquired N/A Interest disposed N/A Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
N/A Interest after change N/A Part 3 – + Closed period
Appendix 3Y Change of Director’s Interest Notice
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3 Doc ID 691538253/v1 Were the interests in the securities or contracts detailed above traded during a + closed period where prior written clearance was required? N/A If so, was prior written clearance provided to allow the trade to proceed during this period? N/A If prior written clearance was provided, on what date was this provided? N/A
PERTH, 29 September 2026 Lycopodium Limited (“ASX: LYL”, “Lycopodium” or “the Company”), a global leader in integrated engineering, project, construction and asset management, is pleased to advise it has been awarded the Engineering and Procurement (EP) services contract for the development of Endeavour Mining’s (“Endeavour”) Assafo-Dibibango (“Assafou”) Gold Project in Côte d’Ivoire. While EP activities have commenced, the project remains subject to Endeavour’s Board of Directors making a final investment decision (FID), expected before year-end 2026. The contract is valued at approximately A$42.9 million for the delivery of the engineering and procurement services for a 5.0 Mtpa carbon-in-leach (CIL) processing plant and associated non- process infrastructure. The Assafou deposit is located on the Tanda-Iguela property in the east of Côte d’Ivoire, approximately 280 kilometres northeast of Abidjan, adjacent to the Ghana border. Situated within the highly prospective Birimian and Tarkwaian geological belts, it is considered one of the most significant discoveries made in West Africa over the past decade and has the potential to be another flagship asset for Endeavour. Lycopodium has a longstanding relationship with Endeavour, having delivered more than five major capital projects over the past 12 years, including the Pre-Feasibility Study (PFS) and Definitive Feasibility Study (DFS) for the Assafou Project. Early works, engineering and design activities, together with the procurement of long-lead items, are progressing under the EP contract awarded to Lycopodium. Continued execution of the contract and advancement to full project implementation remain contingent upon FID approval. Lycopodium’s Managing Director and CEO, Peter De Leo, said: “We are extremely pleased to be given this opportunity to again work with Endeavour in the delivery of another high-quality gold operation in Africa, with Assafou set to become a cornerstone asset for the company.”
Lycopodium Limited ABN 83 098 556 159 W lycopodium.com
Level 5, 1 Adelaide Terrace, East Perth WA 6004, Australia T +61 8 6210 5222
Lycopodium Awarded EPCM Contract for Greatland’s Havieron Project
PERTH, 21 September 2026
Lycopodium Limited (“ASX: LYL”, “Lycopodium” or “the Company”), a global leader in integrated
engineering, project, construction and asset management, is pleased to announce it has been
awarded the Engineering, Procurement and Construction Management (EPCM) contract for delivery of
Greatland Resources Limited (ASX:GGP) Havieron Project in Western Australia.
The contract is valued at A$49.4 million, with Lycopodium engaged as Project delivery partner
responsible for leading the project execution of the preproduction phase, with the scope
encompassing project management, engineering and procurement services, coordination and
management of trade contractors and suppliers, project controls, and construction and
commissioning management as required to support delivery of the project.
Havieron is a high-grade underground gold-copper deposit located in the Paterson Province in the
East Pilbara region of Western Australia, approximately 45 kilometres east of Greatland’s Telfer gold-
copper mine. Greatland will leverage Telfer’s existing processing facility and related infrastructure to
process the ore mined from Havieron. The Telfer mine is one of the largest gold processing facilities in
Australia, comprising two 10 million tonnes per annum (Mtpa) capacity trains.
Delivery of the project has commenced, following receipt of a Limited Notice of Award in early June
2026.
Lycopodium’s Managing Director and CEO, Peter De Leo, said: “Havieron is a world-class, high-grade
gold project and we are very pleased to have this opportunity to support Greatland in the development
of its Telfer Hub strategy, leveraging the existing processing facilities available at Telfer to mine ore from
Havieron.”
Appendix 3Y Change of Director’s Interest Notice
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11
Name of entity LYCOPODIUM LIMITED ABN 83 098 556 159
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director Bruno Ruggiero Date of last notice 2 March 2026
Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Direct or indirect interest Indirect Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.
Luala Pty Ltd Ziziphus Pty Ltd Date of change 15 September 2026 No. of securities held prior to change 479,786 Fully Paid Ordinary Shares 34,617 Class A Performance Rights Number acquired NIL Number disposed 354,711 Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation
$7,753,103 No. of securities held after change
125,075 Fully Paid Ordinary Shares 34,617 Class A Performance Rights
Appendix 3Y Change of Director’s Interest Notice
- See chapter 19 for defined terms.
Appendix 3Y Page 2 01/01/2011
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back On Market Trade
Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
Detail of contract
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change
Part 3 – + Closed period
Were the interests in the securities or contracts detailed above traded during a + closed period where prior written clearance was required? No
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?
20 April 2023 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Indirect Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. Caddy Fox Pty Ltd atf The Leonard Family Trust. The Director is a director of the trustee company and is a beneficiary of the trust. Date of change 10 September 2026 No. of securities held prior to change 902,930 Fully Paid Ordinary Shares Number acquired NIL Number disposed 200,000 Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation $4,200,000 No. of securities held after change 702,930Fully Paid Ordinary Shares
Appendix 3Y Change of Director’s Interest Notice
- See chapter 19 for defined terms. Appendix 3Y Page 201/01/2011 Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back On Market Trade (200,000 shares) Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change Part 3 –
Closed period Were the interests in the securities or contracts detailed above traded during a + closed period where prior written clearance was required? No If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?
12 December 2025 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Indirect Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. De Leo Super Fund (Mr Peter De Leo and Mrs Tiana De Leo) De Leo Nominees Pty Ltd Date of change 10 September 2026 No. of securities held prior to change 909,053 Fully Paid Ordinary Shares 42,848 Class A Performance Rights Number acquired NIL Number disposed 200,000 Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation $4,200,000 No. of securities held after change 709,053 Fully Paid Ordinary Shares 42,848 Class A Performance Rights
Appendix 3Y Change of Director’s Interest Notice
- See chapter 19 for defined terms. Appendix 3Y Page 201/01/2011 Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back On Market Trade (200,000 shares) Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change Part 3 –
Closed period Were the interests in the securities or contracts detailed above traded during a + closed period where prior written clearance was required? No If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?
The Board of Directors (Board) of Lycopodium Limited (Lycopodium or Company) is responsible for the overall corporate governance of the Company and its
subsidiary companies (consolidated entity). The Board governs all matters relating to the strategic direction, policies, practices, management and operations of
the consolidated entity with the aim of protecting the interests of shareholders and other stakeholders, including employees, clients and suppliers, and
creating value for them.
The Board has implemented the Corporate Governance Principles and Recommendations of the ASX Corporate Governance Council to the extent considered
appropriate for the size and nature of the Company’s current operations.
The table below summarises the consolidated entity’s compliance with the Corporate Governance Council’s Corporate Governance Principles and
Recommendations 4
th
Edition, with any exceptions disclosed with reasons provided for not following the recommendations.
The Company has adopted a Corporate Governance Framework which provides the written terms of reference for the Company’s corporate governance
duties.
This Statement is current as at 1 July 2026 and has been approved by the Lycopodium Limited Board of Directors.
Recommendations (4
th
Edition) Comply Explanation
Principal 1: Lay solid foundations for management and oversight
Recommendation 1.1
A listed entity should have and disclose a board charter setting out:
(a) the respective roles and responsibilities of its board and management; and
(b) those matters expressly reserved to the board and those delegated to
management.
YES The Company has adopted a Board Charter that sets out the specific roles and responsibilities of the Board, the Chair and management and includes a description of those matters reserved to the Board and those delegated to management. The Board Charter sets out the specific responsibilities of the Board requirements as to composition, the roles and responsibilities of the Chairman and Managing Director/CEO, the establishment, operation and management of Board Committees, Directors’ access to Company records and information, details of the Board’s relationship with management, details of the Board’s performance review and details of the Board’s disclosure policy. A copy of the Company’s Board Charter, which is part of the Company’s Corporate Governance Framework, is available on the Company’s website.
BRM-POL-L-006_4 - Corporate Governance Statement_FINAL Recommendations (4 th Edition) Comply Explanation
Recommendation 1.2 A listed entity should: (a) undertake appropriate checks before appointing a director or senior executive or putting someone forward for election as a director; and (b) provide security holders with all material information in its possession relevant to a decision on whether or not to elect or re-elect a director.
YES (a) The Company has guidelines for the appointment and selection of the Board in its Corporate Governance Framework. The role of the Nomination Committee is carried out by the full Board. The Company’s Nomination Committee Charter requires the full Board to ensure appropriate checks (including checks in respect of character, experience, education, criminal record and bankruptcy history, as appropriate) are undertaken before appointing a person, or putting forward to security holders a candidate for election, as a Director. (b) Under the Nomination Committee Charter, all material information relevant to a decision on whether or not to elect or re-elect a Director must be provided to security holders in the Notice of Meeting containing the resolution to elect or re-elect a Director. Recommendation 1.3 A listed entity should have a written agreement with each director and senior executive setting out the terms of their appointment.
YES
The Company’s Nomination Committee Charter requires each Director and
senior executive be a party to a written agreement, with the Company
setting out the terms of the Director’s or senior executive’s appointment.
The Company has written agreements in place with each of its Directors
and senior executives.
Recommendation 1.4
The company secretary of a listed entity should be accountable directly to the
Board, through the chair, on all matters to do with the proper functioning of
the board.
YES The Board Charter outlines the roles, responsibilities and accountability of the Company Secretary. In accordance with this, the Company Secretary is accountable directly to the Board, through the Chair, on all matters to do with the proper functioning of the Board.
BRM-POL-L-006_4 - Corporate Governance Statement_FINAL Recommendations (4 th Edition) Comply Explanation Recommendation 1.5 A listed entity should: (a) have and disclose a diversity policy; (b) through its board or a committee of the board set measurable objectives for achieving gender diversity in the composition of its board, senior executives and workforce generally; and (c) disclose in relation to each reporting period:
- the measurable objectives set for that period to achieve gender diversity;
- the entity’s progress towards achieving those objectives; and
- either: (A) the respective proportions of men and women on the board, in senior executive positions and across the whole workforce (including how the entity has defined “senior executive” for these purposes); or (B) if the entity is a “relevant employer” under the Workplace Gender Equality Act, the entity’s most recent “Gender Equality Indicators”, as defined in and published under that Act. If the entity was in the S&P/ASX 300 Index at the commencement of the reporting period, the measurable objective for achieving gender diversity in the composition of its board should be to have not less than 30% of its directors of each gender within a specified period.
PARTIALLY YES
The Company has adopted a Diversity Policy which outlines the
policies for the employment of people and career advancement based
on merit.
The Diversity Policy is available on the Company’s website.
The Company has not adopted measurable objectives.
The Company discloses WGEA results to employees and shareholders
via the Sustainability Report, with public data available on the WGEA
platform.
Recommendation 1.6 A listed entity should: (a) have and disclose a process for periodically evaluating the performance of the board, its committees and individual directors; and
YES (a) The full Board participates in evaluating the performance of the Board as a whole and contribution of each Director to the effectiveness of the Board, including a review of qualifications, skills, competencies and experience. Assessment of the performance of the Board, Committees and individual Directors is undertaken on an annual basis. If deemed necessary, this may be carried out with the assistance of an independent advisor.
BRM-POL-L-006_4 - Corporate Governance Statement_FINAL
Recommendations (4
th
Edition) Comply Explanation
(b) disclose for each reporting period whether a performance evaluation has
been undertaken in accordance with that process during or in respect of
that period.
(b) The Company’s Corporate Governance Framework requires the
Company to disclose whether or not performance evaluations were
conducted during each reporting period. A review of the Board’s
performance was conducted during the year.
Recommendation 1.7
A listed entity should:
(a) have and disclose a process for evaluating the performance of its senior
executives at least once every reporting period; and
(b) disclose for each reporting period whether a performance evaluation has
been undertaken in accordance with that process during or in respect of
that period.
YES
(a) The Company has in place a formal process for evaluating the
performance of all employees including the Company’s key
management personnel and senior executives on an annual basis. The
Remuneration Committee is responsible for reviewing the
performance evaluations for key management personnel and senior
executives, evaluating the remuneration of the Company’s key
management personnel, senior executives, individual Directors on an
annual basis. The findings of the Remuneration Committee are
reported to the Board for final approval.
(b) The Company’s Corporate Governance Framework requires the
Company to undertake performance evaluations during each
reporting period.
BRM-POL-L-006_4 - Corporate Governance Statement_FINAL Recommendations (4 th Edition) Comply Explanation Principle 2: Structure the board to be effective and add value Recommendation 2.1 The Board of a listed entity should: (a) have a nomination committee which:
- has at least three members, a majority of whom are independent directors; and
- is chaired by an independent director,
and disclose: - the charter of the committee;
- the members of the committee; and
- as at the end of each reporting period, the number of times the committee met throughout the period and the individual attendances of the members at those meetings; or (b) if it does not have a nomination committee, disclose that fact and the process it employs to address board succession issues and to ensure that the board has the appropriate balance of skills, knowledge, experience, independence and diversity to enable it to discharge its duties and responsibilities effectively.
Partially YES (a) The role of the Nomination Committee is carried out by the full Board, which has a majority of non-executive directors. The Nomination Committee is chaired by an independent director. When the Board meets in its capacity as The Nomination Committee it is chaired by an independent director. The Nomination Committee charter is on the Company’s website. The members and attendance are disclosed in the Company’s Annual Report.
Recommendation 2.2 A listed entity should have and disclose a board skills matrix setting out the mix of skills that the Board currently has or is looking to achieve in its membership.
YES The Company has a Board skills matrix, which sets out the mix of skills that the Board currently has or is looking to achieve in its membership. Full details as to each Director’s and senior executive’s relevant skills and experience are available on the Company’s website.
BRM-POL-L-006_4 - Corporate Governance Statement_FINAL Recommendations (4 th Edition) Comply Explanation Recommendation 2.3 A listed entity should disclose: (a) the names of the directors considered by the board to be independent directors; (b) if a director has an interest, position or relationship of the type described in Box 2.3 but the board is of the opinion that it does not compromise the independence of the director, the nature of the interest, position or relationship in question and an explanation of why the board is of that opinion; and (c) the length of service of each director.
YES (a) The Board Charter requires the disclosure of the names of Directors considered by the Board to be independent. The Company will disclose those Directors it considers to be independent in its Annual Report and on its website. (b) There are three independent Directors. (c) The Company’s Annual Report will disclose the length of service of each Director, as at the end of each financial year. Recommendation 2.4 A majority of the board of a listed entity should be independent directors.
NO
The Company does not comply with this recommendation.
The Board currently comprises a total of seven directors, of whom only
three are considered independent. The Board comprises of a majority of
non-executive directors.
The Board considers that the shareholders are well served with the blend
of director types, consisting non-executive, independent and executive, all
of whom have a vested interest in the success of the Company.
Recommendation 2.5
The chair of the board of a listed entity should be an independent director and,
in particular, should not be the same person as the CEO of the entity.
YES The Chair of the Board is a non-executive, independent director. The role of Chairperson and Managing Director/CEO are not fulfilled by the same person and are separated, whereby the Chairperson bears the responsibility for providing guidance on the corporate direction of the group and leadership to the Board, and the Managing Director/CEO has executive responsibility for the Company’s day-to-day business activities. The Chairperson and the Managing Director/CEO are not related. Recommendation 2.6 A listed entity should have a program for inducting new directors and for periodically reviewing whether there is a need for existing directors to undertake professional development to maintain the skills and knowledge needed to perform their role as directors effectively.
YES The Company requires the full Board to be responsible for the approval and review of induction and continuing professional development programs and procedures for Directors to ensure that they can effectively discharge their responsibilities.
BRM-POL-L-006_4 - Corporate Governance Statement_FINAL Recommendations (4 th Edition) Comply Explanation Principle 3: Instil a culture of acting lawfully, ethically and responsibly Recommendation 3.1 A listed entity should articulate and disclose its values.
YES The Company’s values are articulated and disclosed on its website and internally on the Company’s intranet. Recommendation 3.2 A listed entity should: (a) have and disclose a code of conduct for its directors, senior executives and employees; and (b) ensure that the board or a committee of the board is informed of any material breaches of that code.
YES (a) The Company’s Corporate Code of Conduct applies to the Company’s Directors, senior executives and employees. The Company’s Corporate Code of Conduct (which forms part of the Corporate Governance Framework) is available on the Company’s website. (b) The Risk Committee monitors compliance with the Corporate Code of Conduct and informs the Board of any material breaches. Recommendation 3.3 A listed entity should: (a) have and disclose a whistleblower policy; and (b) ensure that the board or a committee of the board is informed of any material incidents reported under that policy.
YES
(a) The Company has a Whistleblower Policy which is available on its
website.
(b) The Risk Committee monitors reports made under the Whistleblower
Policy and informs the Board of any material incidents.
Recommendation 3.4
A listed entity should:
(a) have and disclose an anti-bribery and corruption policy; and
(b) ensure that the board or a committee of the board is informed of any
material breaches of that policy.
YES
(a) The Company has an Anti-Bribery and Corruption Policy which is
available on its website.
(b) The Risk Committee monitors compliance with the Anti-Bribery and
Corruption Policy and informs the Board of any material breaches.
BRM-POL-L-006_4 - Corporate Governance Statement_FINAL Recommendations (4 th Edition) Comply Explanation Principle 4: Safeguard the integrity of corporate reports Recommendation 4.1 The board of a listed entity should: (a) have an audit committee which:
- has at least three members, all of whom are non-executive directors and a majority of whom are independent directors; and
- is chaired by an independent director, who is not the chair of the
board,
and disclose: - the charter of the committee;
- the relevant qualifications and experience of the members of the committee; and
- in relation to each reporting period, the number of times the committee met throughout the period and the individual attendances of the members at those meetings; or (b) if it does not have an audit committee, disclose that fact and the processes it employs that independently verify and safeguard the integrity of its corporate reporting, including the processes for the appointment and removal of the external auditor and the rotation of the audit engagement partner.
PARTIALLY YES
(a) The Company has an Audit Committee. The Company’s Corporate
Governance Framework contains an Audit Committee Charter.
The Audit Committee consists of three Directors, two of which are
non-executive and considered to be independent. The Chair is
independent.
The Audit Committee Charter is available on the Company’s website.
The members of the Audit Committee, their relevant qualification and
experience, the number of times the committee meets during each
financial year, and the individual attendances of the meetings are
disclosed in the Annual Report.
BRM-POL-L-006_4 - Corporate Governance Statement_FINAL Recommendations (4 th Edition) Comply Explanation Recommendation 4.2 The board of a listed entity should, before it approves the entity’s financial statements for a financial period, receive from its CEO and CFO a declaration that, in their opinion, the financial records of the entity have been properly maintained and that the financial statements comply with the appropriate accounting standards and give a true and fair view of the financial position and performance of the entity and that the opinion has been formed on the basis of a sound system of risk management and internal control which is operating effectively.
YES
The Company’s Audit Committee Charter requires the Managing
Director/CEO and CFO to provide a sign-off on these terms.
The Company obtains a sign off on these terms for each of its financial
statements in each financial year.
Recommendation 4.3
A listed entity should disclose its process to verify the integrity of any periodic
corporate report it releases to the market that is not audited or reviewed by an
external auditor.
YES All financial reports released to the market are audited or reviewed by an external auditor. Principle 5: Make timely and balanced disclosure Recommendation 5.1 A listed entity should have and disclose a written policy for complying with its continuous disclosure obligations under listing rule 3.1.
YES
The Board Charter provides details of the Company’s disclosure policy. In
addition, the Corporate Governance Framework details the Company’s
disclosure requirements as required by the ASX Listing Rules and other
relevant legislation.
The Company’s Continuous Disclosure Policy is available on the Company
website.
Recommendation 5.2
A listed entity should ensure that its board receives copies of all material
market announcements promptly after they have been made.
YES All material market announcements are reviewed and approved by the Board prior to release. Recommendation 5.3 A listed entity that gives a new and substantive investor or analyst presentation should release a copy of the presentation materials on the ASX Market Announcements Platform ahead of the presentation.
YES All investor presentations are released on the ASX Market Announcements Platform prior to disseminating to investors/analysts.
BRM-POL-L-006_4 - Corporate Governance Statement_FINAL Principle 6: Respect the rights of security holders Recommendation 6.1 A listed entity should provide information about itself and its governance to investors via its website.
YES Information about the Company and its governance is available on the Company’s website. Recommendation 6.2 A listed entity should have an investor relations program that facilitates effective two-way communication with investors.
YES The Company has adopted a shareholder communication strategy which aims to promote and facilitate effective two-way communication with investors. The strategy outlines a range of ways in which information is communicated to shareholders. Recommendation 6.3 A listed entity should disclose how it facilitates and encourages participation at meetings of security holders.
YES The Company maintains a website that provides comprehensive operational information and invites shareholder enquiries. The Company also provides an operational report to shareholders on a six monthly basis in addition to advising shareholders on a timely basis of any material changes to operations via ASX announcements and the Company’s website. All shareholders receive an invitation to attend General Meetings. Recommendation 6.4 A listed entity should ensure that all substantive resolutions at a meeting of security holders are decided by a poll rather than by a show of hands.
YES The Company’s forum for proposing substantive resolutions is the Annual General Meeting, at which resolutions are decided by a poll open to all shareholders, not by a show of hands of those present. Recommendation 6.5 A listed entity should give security holders the option to receive communications from, and send communications to, the entity and its security registry electronically.
YES The shareholder communication strategy provides that security holders can elect to receive documents relating to their shareholding, including the Company’s Annual Report and meeting-related documents, electronically or in paper copy. Details for communicating with the Company and its security registry electronically, by telephone or in writing, are available on the Company’s website.
BRM-POL-L-006_4 - Corporate Governance Statement_FINAL Principle 7: Recognise and manage risk Recommendation 7.1 The Board of a listed entity should: (a) have a committee or committees to oversee risk, each of which:
- has at least three members, a majority of whom are independent directors; and
- is chaired by an independent director,
and disclose: - the charter of the committee;
- the members of the committee; and
- as at the end of each reporting period, the number of times the committee met throughout the period and the individual attendances of the members at those meetings; or (b) if it does not have a risk committee or committees that satisfy (a) above, disclose that fact and the processes it employs for overseeing the entity’s risk management framework.
PARTIALLY YES
(a) The Company has a Risk Committee.
The Risk Committee consists of four Directors, two of which are non-
executive and considered to be independent. The Chair is
independent. All Committee members are appropriately qualified.
The Risk Committee Charter and Risk Management Policy are
available on the Company’s website.
The members of the Risk Committee, the number of times the
committee meets during each financial year, and the individual
attendances of the meetings are disclosed in the Annual Report.
Recommendation 7.2
The board or a committee of the board should:
(a) review the entity’s risk management framework at least annually to satisfy
itself that it continues to be sound and that the entity is operating with
due regard to the risk appetite set by the board; and
(b) disclose in relation to each reporting period, whether such a review has
taken place.
YES (b) The Board reviews the Company’s Risk Management Policy annually to satisfy itself that the Company’s risk management internal control framework continues to be sound and that the entity is operating with due regard to the risk appetite set by the Board. (c) The Company discloses whether such a review has taken place in the Annual Report. Recommendation 7.3 A listed entity should disclose: (a) if it has an internal audit function, how the function is structured and what role it performs; or
YES (a) The Risk Committee nominates internal audits conducted each year by the subject matter experts, either internally and externally provided, with findings reviewed by the Risk Committee and reported to the Board. Additionally, internal assurance reviews are embedded
BRM-POL-L-006_4 - Corporate Governance Statement_FINAL
(b) if it does not have an internal audit function, that fact and the processes it
employs for evaluating and continually improving the effectiveness of its
governance, risk management and internal control processes.
within established corporate and operational procedures across the
business.
(b) The Audit Committee Charter and Risk Committee requires that these
Committees monitor the need for an internal audit function.
Recommendation 7.4
A listed entity should disclose whether it has any material exposure to
environmental or social risks and, if it does, how it manages or intends to
manage those risks.
YES
The Risk Management Policy requires the Board to assist management in
determining whether the Company has any material exposure to
environmental or social risks and, if it does, how it intends to manage
those risks.
The Company discloses this information in its Annual Report, Sustainability
Report and on the ASX website as part of its continuous disclosure
obligations.
Principle 8: Remunerate fairly and responsibly
Recommendation 8.1
The board of a listed entity should:
(a) have a remuneration committee which:
- has at least three members, a majority of whom are independent directors; and
- is chaired by an independent director and disclose:
- the charter of the committee;
- the members of the committee; and
- as at the end of each reporting period, the number of times the committee met throughout the period and the individual attendances of the members at those meetings; or (b) if it does not have a remuneration committee, disclose that fact and the processes it employs for setting the level and composition of remuneration for directors and senior executives and ensuring that such remuneration is appropriate and not excessive.
YES (a) The Company has a Remuneration Committee. The Company’s Corporate Governance Framework contains a Remuneration Committee Charter. The Remuneration Committee consists of three Directors, all of which are non-executive, with two of these independent. The chair of the Remuneration Committee is an independent Director. The Remuneration Committee Charter is available on the Company’s website. The members of the Remuneration Committee, the number of times the committee meets during each financial year, and the individual attendances of the meetings are disclosed in the Annual Report.
BRM-POL-L-006_4 - Corporate Governance Statement_FINAL
Recommendation 8.2 A listed entity should separately disclose its policies and practices regarding the remuneration of non-executive directors and the remuneration of executive directors and other senior executives.
YES The Company’s Corporate Governance Framework requires the Board to disclose its policies and practices regarding the remuneration of directors and senior executives. Recommendation 8.3 A listed entity which has an equity-based remuneration scheme should: (a) have a policy on whether participants are permitted to enter into transactions (whether through the use of derivatives or otherwise) which limit the economic risk of participating in the scheme; and (b) disclose that policy or a summary of it.
YES
(a) The Company’s Securities Trading Policy prohibits hedging
arrangements, dealing in derivatives or entering into any
arrangements that vary the economic risk related to the Company’s
securities.
The Company’s Securities Trading Policy is available on the
Company’s website.
Lycopodium Limited Preliminary Final Report ABN 83 098 556 159 for the year ended 30 June 2026
LYCOPODIUM LIMITED ABN 83 098 556 159 Preliminary final report For the year ended 30 June 2026 Appendix 4E
Reporting period & previous corresponding period The current reporting period is for the year ended 30 June 2026 The prior period is for the year ended 30 June 2025
Results for announcement to the market A$’000 Revenue from ordinary activities Up 11.2% To $377,549
Revenue excluding interest income Up 11.5% To $375,791
Profit after tax attributable to members Down 4.9% To $40,169
Profit for the period attributable to members Down 4.9% To $40,169
Dividends Amount per security Franked amount per security Financial Year Ended 30 June 2026 Final dividend Interim dividend
37.0 cents 22.0 cents
37.0 cents 22.0 cents Financial Year Ended 30 June 2025 Final dividend Interim dividend
25.0 cents 10.0 cents
25.0 cents 10.0 cents
Dividend payments Date the final 2026 dividend is payable 2 October 2026
Record date to determine entitlements to the dividend 18 September 2026
Lycopodium Limited Preliminary Final Report ABN 83 098 556 159 for the year ended 30 June 2026
Date final dividend was declared 18 August 2026 Total dividends per security (interim plus final)
2026 2025 Ordinary Securities 59 cents 35 cents
Total dividends paid on all securities
2026 A$’000 2025 A$’000 Ordinary Securities 18,678 19,870 Total 18,678 19,870
Net tangible assets 30 June 2026 Cents per share 30 June 2025 Cents per share Net tangible asset backing per ordinary security 392 cents 363 cents
Control gained over entities having material effect Lycopodium gained control over the below entities during the year ended 30 June 2026 –
- SAXUM Engineering Pty Ltd (incorporated in Australia)
- SAXUM Ingenieria S.A (incorporated in Argentina)
- SAXUM Consultoria e Engenharia Ltd (incorporated in Brazil)
- SAXUM Engineering LLC (incorporated in the USA)
Loss of control of entities having material effect No control over any material entities was lost during the year ended 30 June 2026
Lycopodium Limited Preliminary Final Report ABN 83 098 556 159 for the year ended 30 June 2026
Details of associates and joint arrangements Lycopodium has the following associates: The Consolidated Entity has a 31% interest in ECG Engineering Pty Ltd, a private company established to provide specialised electrical engineering services to the mining, utilities, materials handling and industrial industries. The Consolidated Entity has a 49% interest in Kholo Marine & Minerals Pty Ltd, a private company established to provide project delivery services where the mineral or targeted resource or project is situated in South Africa. Lycopodium has the following joint ventures: The Consolidated Entity has a 40% interest in Mondium Pty Ltd, a private company established to provide engineering, procurement and construction services. Mondium is able to provide full project development and execution services, from conceptual early design through complete project EPC delivery. The Consolidated Entity has a 50% interest in Orway IQ Pty Ltd, a private company established to provide remote optimisation consulting services to the minerals processing industry. The Company has a 50% interest in LPN Dry Mining Services (Pty) Ltd, a private company established to provide engineering, procurement and construction services.
Annual Meeting The annual general meeting will be held as follows:
Place Level 5
1 Adelaide Terrace, East Perth WA
Date 12 November 2026
Time 10.30am
Approximate date the annual report will
be available
8 October 2026
This report is based on accounts which have been audited.
Justine Campbell Date: 18 August 2026 Company Secretary
Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity LYCOPODIUM LIMITED
ABN/ARBN Financial year ended: 83 098 556 159 30 June 2026 Our corporate governance statement 1 for the period above can be found at: 2
☐ These pages of our annual report:
☒ This URL on our website: www.lycopodium.com
The Corporate Governance Statement is accurate and up to date as at 18 August 2026 and has been approved by the board. The annexure includes a key to where our corporate governance disclosures can be located. 3
Date: 18 August 2026
Name of authorised officer authorising lodgement:
Justine Campbell
1 “Corporate governance statement” is defined in Listing Rule 19.12 to mean the statement referred to in Listing Rule 4.10.3 which discloses the extent to which an entity has followed the recommendations set by the ASX Corporate Governance Council during a particular reporting period. Listing Rule 4.10.3 requires an entity that is included in the official list as an ASX Listing to include in its annual report either a corporate governance statement that meets the requirements of that rule or the URL of the page on its website where such a statement is located. The corporate governance statement must disclose the extent to which the entity has followed the recommendations set by the ASX Corporate Governance Council during the reporting period. If the entity has not followed a recommendation for any part of the reporting period, its corporate governance statement must separately identify that recommendation and the period during which it was not followed and state its reasons for not following the recommendation and what (if any) alternative governance practices it adopted in lieu of the recommendation during that period. Under Listing Rule 4.7.4, if an entity chooses to include its corporate governance statement on its website rather than in its annual report, it must lodge a copy of the corporate governance statement with ASX at the same time as it lodges its annual report with ASX. The corporate governance statement must be current as at the effective date specified in that statement for the purposes of Listing Rule 4.10.3. Under Listing Rule 4.7.3, an entity must also lodge with ASX a completed Appendix 4G at the same time as it lodges its annual report with ASX. The Appendix 4G serves a dual purpose. It acts as a key designed to assist readers to locate the governance disclosures made by a listed entity under Listing Rule 4.10.3 and under the ASX Corporate Governance Council’s recommendations. It also acts as a verification tool for listed entities to confirm that they have met the disclosure requirements of Listing Rule 4.10.3. The Appendix 4G is not a substitute for, and is not to be confused with, the entity's corporate governance statement. They serve different purposes and an entity must produce each of them separately. 2 Tick whichever option is correct and then complete the page number(s) of the annual report, or the URL of the web page, where your corporate governance statement can be found. You can, if you wish, delete the option which is not applicable. 3 Throughout this form, where you are given two or more options to select, you can, if you wish, delete any option which is not applicable and just retain the option that is applicable. If you select an option that includes “OR” at the end of the selection and you delete the other options, you can also, if you wish, delete the “OR” at the end of the selection. See notes 4 and 5 below for further instructions on how to complete this form.
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 2 ANNEXURE – KEY TO CORPORATE GOVERNANCE DISCLOSURES
Corporate Governance Council recommendation Where a box below is ticked, 4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement: Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are: 5
PRINCIPLE 1 – LAY SOLID FOUNDATIONS FOR MANAGEMENT AND OVERSIGHT 1.1 A listed entity should have and disclose a board charter setting out: (a) the respective roles and responsibilities of its board and management; and (b) those matters expressly reserved to the board and those delegated to management. ☒ and we have disclosed a copy of our board charter at: www.lycopodium.com
☐ set out in our Corporate Governance Statement OR ☐ we are an externally managed entity and this recommendation is therefore not applicable 1.2 A listed entity should: (a) undertake appropriate checks before appointing a director or senior executive or putting someone forward for election as a director; and (b) provide security holders with all material information in its possession relevant to a decision on whether or not to elect or re-elect a director. ☒
☐ set out in our Corporate Governance Statement OR ☐ we are an externally managed entity and this recommendation is therefore not applicable 1.3 A listed entity should have a written agreement with each director and senior executive setting out the terms of their appointment. ☒
☐ set out in our Corporate Governance Statement OR ☐ we are an externally managed entity and this recommendation is therefore not applicable 1.4 The company secretary of a listed entity should be accountable directly to the board, through the chair, on all matters to do with the proper functioning of the board. ☒
☐ set out in our Corporate Governance Statement OR ☐ we are an externally managed entity and this recommendation is therefore not applicable
4 Tick the box in this column only if you have followed the relevant recommendation in full for the whole of the period above. Where the recommendation has a disclosure obligation attached, you must insert the location where that disclosure has been made, where indicated by the line with “insert location” underneath. If the disclosure in question has been made in your corporate governance statement, you need only insert “our corporate governance statement”. If the disclosure has been made in your annual report, you should insert the page number(s) of your annual report (eg “pages 10-12 of our annual report”). If the disclosure has been made on your website, you should insert the URL of the web page where the disclosure has been made or can be accessed (eg “www.entityname.com.au/corporate governance/charters/”). 5 If you have followed all of the Council’s recommendations in full for the whole of the period above, you can, if you wish, delete this column from the form and re-format it.
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 3 Corporate Governance Council recommendation Where a box below is ticked, 4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement: Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are: 5
1.5 A listed entity should: (a) have and disclose a diversity policy; (b) through its board or a committee of the board set measurable objectives for achieving gender diversity in the composition of its board, senior executives and workforce generally; and (c) disclose in relation to each reporting period: (1) the measurable objectives set for that period to achieve gender diversity; (2) the entity’s progress towards achieving those objectives; and (3) either: (A) the respective proportions of men and women on the board, in senior executive positions and across the whole workforce (including how the entity has defined “senior executive” for these purposes); or (B) if the entity is a “relevant employer” under the Workplace Gender Equality Act, the entity’s most recent “Gender Equality Indicators”, as defined in and published under that Act. If the entity was in the S&P / ASX 300 Index at the commencement of the reporting period, the measurable objective for achieving gender diversity in the composition of its board should be to have not less than 30% of its directors of each gender within a specified period. ☐ and we have disclosed a copy of our diversity policy at: ......................................................................................... [insert location] and we have disclosed the information referred to in paragraph (c) at: ......................................................................................... [insert location] and if we were included in the S&P / ASX 300 Index at the commencement of the reporting period our measurable objective for achieving gender diversity in the composition of its board of not less than 30% of its directors of each gender within a specified period. ☒ set out in our Corporate Governance Statement OR ☐ we are an externally managed entity and this recommendation is therefore not applicable 1.6 A listed entity should: (a) have and disclose a process for periodically evaluating the performance of the board, its committees and individual directors; and (b) disclose for each reporting period whether a performance evaluation has been undertaken in accordance with that process during or in respect of that period. ☐ and we have disclosed the evaluation process referred to in paragraph (a) at: ......................................................................................... [insert location] and whether a performance evaluation was undertaken for the reporting period in accordance with that process at: ......................................................................................... [insert location] ☒ set out in our Corporate Governance Statement OR ☐ we are an externally managed entity and this recommendation is therefore not applicable
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 4 Corporate Governance Council recommendation Where a box below is ticked, 4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement: Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are: 5
1.7 A listed entity should: (a) have and disclose a process for evaluating the performance of its senior executives at least once every reporting period; and (b) disclose for each reporting period whether a performance evaluation has been undertaken in accordance with that process during or in respect of that period. ☐ and we have disclosed the evaluation process referred to in paragraph (a) at: ......................................................................................... [insert location] and whether a performance evaluation was undertaken for the reporting period in accordance with that process at: ......................................................................................... [insert location] ☒ set out in our Corporate Governance Statement OR ☐ we are an externally managed entity and this recommendation is therefore not applicable
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 5 Corporate Governance Council recommendation Where a box below is ticked, 4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement: Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are: 5
PRINCIPLE 2 - STRUCTURE THE BOARD TO BE EFFECTIVE AND ADD VALUE 2.1 The board of a listed entity should: (a) have a nomination committee which: (1) has at least three members, a majority of whom are independent directors; and (2) is chaired by an independent director, and disclose: (3) the charter of the committee; (4) the members of the committee; and (5) as at the end of each reporting period, the number of times the committee met throughout the period and the individual attendances of the members at those meetings; or (b) if it does not have a nomination committee, disclose that fact and the processes it employs to address board succession issues and to ensure that the board has the appropriate balance of skills, knowledge, experience, independence and diversity to enable it to discharge its duties and responsibilities effectively. ☐ [If the entity complies with paragraph (a):] and we have disclosed a copy of the charter of the committee at: ......................................................................................... [insert location] and the information referred to in paragraphs (4) and (5) at: ......................................................................................... [insert location] [If the entity complies with paragraph (b):] and we have disclosed the fact that we do not have a nomination committee and the processes we employ to address board succession issues and to ensure that the board has the appropriate balance of skills, knowledge, experience, independence and diversity to enable it to discharge its duties and responsibilities effectively at: www.lycopodium.com
☒ set out in our Corporate Governance Statement OR ☐ we are an externally managed entity and this recommendation is therefore not applicable 2.2 A listed entity should have and disclose a board skills matrix setting out the mix of skills that the board currently has or is looking to achieve in its membership. ☐ and we have disclosed our board skills matrix at: ......................................................................................... [insert location] ☒ set out in our Corporate Governance Statement OR ☐ we are an externally managed entity and this recommendation is therefore not applicable
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 6 Corporate Governance Council recommendation Where a box below is ticked, 4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement: Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are: 5
2.3 A listed entity should disclose: (a) the names of the directors considered by the board to be independent directors; (b) if a director has an interest, position, affiliation or relationship of the type described in Box 2.3 but the board is of the opinion that it does not compromise the independence of the director, the nature of the interest, position or relationship in question and an explanation of why the board is of that opinion; and (c) the length of service of each director. ☒ and we have disclosed the names of the directors considered by the board to be independent directors at: www.lycopodium.com and, where applicable, the information referred to in paragraph (b) at: Annual Report 2026 pages 13-15
and the length of service of each director at: Annual Report 2026 pages 13-15
☐ set out in our Corporate Governance Statement 2.4 A majority of the board of a listed entity should be independent directors. ☐ ☒ set out in our Corporate Governance Statement OR ☐ we are an externally managed entity and this recommendation is therefore not applicable 2.5 The chair of the board of a listed entity should be an independent director and, in particular, should not be the same person as the CEO of the entity. ☒ ☐ set out in our Corporate Governance Statement OR ☐ we are an externally managed entity and this recommendation is therefore not applicable 2.6 A listed entity should have a program for inducting new directors and for periodically reviewing whether there is a need for existing directors to undertake professional development to maintain the skills and knowledge needed to perform their role as directors effectively. ☒ ☐ set out in our Corporate Governance Statement OR ☐ we are an externally managed entity and this recommendation is therefore not applicable
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 7 Corporate Governance Council recommendation Where a box below is ticked, 4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement: Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are: 5
PRINCIPLE 3 – INSTIL A CULTURE OF ACTING LAWFULLY, ETHICALLY AND RESPONSIBLY 3.1 A listed entity should articulate and disclose its values. ☒ and we have disclosed our values at: www.lycopodium.com
☐ set out in our Corporate Governance Statement 3.2 A listed entity should: (a) have and disclose a code of conduct for its directors, senior executives and employees; and (b) ensure that the board or a committee of the board is informed of any material breaches of that code. ☒ and we have disclosed our code of conduct at: www.lycopodium.com
☐ set out in our Corporate Governance Statement 3.3 A listed entity should: (a) have and disclose a whistleblower policy; and (b) ensure that the board or a committee of the board is informed of any material incidents reported under that policy. ☒ and we have disclosed our whistleblower policy at: www.lycopodium.com
☐ set out in our Corporate Governance Statement 3.4 A listed entity should: (a) have and disclose an anti-bribery and corruption policy; and (b) ensure that the board or committee of the board is informed of any material breaches of that policy. ☒ and we have disclosed our anti-bribery and corruption policy at: www.lycopodium.com
☐ set out in our Corporate Governance Statement
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 8 Corporate Governance Council recommendation Where a box below is ticked, 4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement: Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are: 5
PRINCIPLE 4 – SAFEGUARD THE INTEGRITY OF CORPORATE REPORTS 4.1 The board of a listed entity should: (a) have an audit committee which: (1) has at least three members, all of whom are non- executive directors and a majority of whom are independent directors; and (2) is chaired by an independent director, who is not the chair of the board, and disclose: (3) the charter of the committee; (4) the relevant qualifications and experience of the members of the committee; and (5) in relation to each reporting period, the number of times the committee met throughout the period and the individual attendances of the members at those meetings; or (b) if it does not have an audit committee, disclose that fact and the processes it employs that independently verify and safeguard the integrity of its corporate reporting, including the processes for the appointment and removal of the external auditor and the rotation of the audit engagement partner. ☐ [If the entity complies with paragraph (a):] and we have disclosed a copy of the charter of the committee at: www.lycopodium.com and the information referred to in paragraphs (4) and (5) at: Annual Report 2026 pages 13-15
[If the entity complies with paragraph (b):] and we have disclosed the fact that we do not have an audit committee and the processes we employ that independently verify and safeguard the integrity of our corporate reporting, including the processes for the appointment and removal of the external auditor and the rotation of the audit engagement partner at: ......................................................................................... [insert location] ☒ set out in our Corporate Governance Statement 4.2 The board of a listed entity should, before it approves the entity’s financial statements for a financial period, receive from its CEO and CFO a declaration that, in their opinion, the financial records of the entity have been properly maintained and that the financial statements comply with the appropriate accounting standards and give a true and fair view of the financial position and performance of the entity and that the opinion has been formed on the basis of a sound system of risk management and internal control which is operating effectively. ☒ ☐ set out in our Corporate Governance Statement 4.3 A listed entity should disclose its process to verify the integrity of any periodic corporate report it releases to the market that is not audited or reviewed by an external auditor. ☒ ☐ set out in our Corporate Governance Statement
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 9 Corporate Governance Council recommendation Where a box below is ticked, 4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement: Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are: 5
PRINCIPLE 5 – MAKE TIMELY AND BALANCED DISCLOSURE 5.1 A listed entity should have and disclose a written policy for complying with its continuous disclosure obligations under listing rule 3.1. ☒ and we have disclosed our continuous disclosure compliance policy at: www.lycopodium.com
☐ set out in our Corporate Governance Statement 5.2 A listed entity should ensure that its board receives copies of all material market announcements promptly after they have been made. ☒ ☐ set out in our Corporate Governance Statement 5.3 A listed entity that gives a new and substantive investor or analyst presentation should release a copy of the presentation materials on the ASX Market Announcements Platform ahead of the presentation. ☒ ☐ set out in our Corporate Governance Statement PRINCIPLE 6 – RESPECT THE RIGHTS OF SECURITY HOLDERS 6.1 A listed entity should provide information about itself and its governance to investors via its website. ☒ and we have disclosed information about us and our governance on our website at: www.lycopodium.com
☐ set out in our Corporate Governance Statement 6.2 A listed entity should have an investor relations program that facilitates effective two-way communication with investors. ☒ ☐ set out in our Corporate Governance Statement 6.3 A listed entity should disclose how it facilitates and encourages participation at meetings of security holders. ☒ and we have disclosed how we facilitate and encourage participation at meetings of security holders at: www.lycopodium.com
☐ set out in our Corporate Governance Statement 6.4 A listed entity should ensure that all substantive resolutions at a meeting of security holders are decided by a poll rather than by a show of hands. ☒ ☐ set out in our Corporate Governance Statement
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 10 Corporate Governance Council recommendation Where a box below is ticked, 4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement: Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are: 5
6.5 A listed entity should give security holders the option to receive communications from, and send communications to, the entity and its security registry electronically. ☒ ☐ set out in our Corporate Governance Statement PRINCIPLE 7 – RECOGNISE AND MANAGE RISK 7.1 The board of a listed entity should: (a) have a committee or committees to oversee risk, each of which: (1) has at least three members, a majority of whom are independent directors; and (2) is chaired by an independent director, and disclose: (3) the charter of the committee; (4) the members of the committee; and (5) as at the end of each reporting period, the number of times the committee met throughout the period and the individual attendances of the members at those meetings; or (b) if it does not have a risk committee or committees that satisfy (a) above, disclose that fact and the processes it employs for overseeing the entity’s risk management framework. ☐ [If the entity complies with paragraph (a):] and we have disclosed a copy of the charter of the committee at: www.lycopodium.com and the information referred to in paragraphs (4) and (5) at: Annual Report 2026 pages 13-15
☐
[If the entity complies with paragraph (b):]
and we have disclosed the fact that we do not have a risk committee
or committees that satisfy (a) and the processes we employ for
overseeing our risk management framework at:
.........................................................................................
[insert location]
☒ set out in our Corporate Governance Statement
7.2 The board or a committee of the board should:
(a) review the entity’s risk management framework at least
annually to satisfy itself that it continues to be sound and
that the entity is operating with due regard to the risk
appetite set by the board; and
(b) disclose, in relation to each reporting period, whether
such a review has taken place.
☒
and we have disclosed whether a review of the entity’s risk
management framework was undertaken during the reporting period
at:
set out in our Corporate Governance Statement
☐ set out in our Corporate Governance Statement
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 11 Corporate Governance Council recommendation Where a box below is ticked, 4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement: Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are: 5
7.3 A listed entity should disclose: (a) if it has an internal audit function, how the function is structured and what role it performs; or (b) if it does not have an internal audit function, that fact and the processes it employs for evaluating and continually improving the effectiveness of its governance, risk management and internal control processes. ☐ [If the entity complies with paragraph (a):] and we have disclosed how our internal audit function is structured and what role it performs at: ......................................................................................... [insert location] [If the entity complies with paragraph (b):] and we have disclosed the fact that we do not have an internal audit function and the processes we employ for evaluating and continually improving the effectiveness of our risk management and internal control processes at: ......................................................................................... [insert location] ☒ set out in our Corporate Governance Statement 7.4 A listed entity should disclose whether it has any material exposure to environmental or social risks and, if it does, how it manages or intends to manage those risks. ☒ and we have disclosed whether we have any material exposure to environmental and social risks at: www.lycopodium.com
and, if we do, how we manage or intend to manage those risks at: Annual Report 2026 pages 9-11 ☐ set out in our Corporate Governance Statement
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 12 Corporate Governance Council recommendation Where a box below is ticked, 4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement: Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are: 5
PRINCIPLE 8 – REMUNERATE FAIRLY AND RESPONSIBLY 8.1 The board of a listed entity should: (a) have a remuneration committee which: (1) has at least three members, a majority of whom are independent directors; and (2) is chaired by an independent director, and disclose: (3) the charter of the committee; (4) the members of the committee; and (5) as at the end of each reporting period, the number of times the committee met throughout the period and the individual attendances of the members at those meetings; or (b) if it does not have a remuneration committee, disclose that fact and the processes it employs for setting the level and composition of remuneration for directors and senior executives and ensuring that such remuneration is appropriate and not excessive. ☒ [If the entity complies with paragraph (a):] and we have disclosed a copy of the charter of the committee at: www.lycopodium.com and the information referred to in paragraphs (4) and (5) at: Annual Report 2026 pages 13-15
☐ [If the entity complies with paragraph (b):] and we have disclosed the fact that we do not have a remuneration committee and the processes we employ for setting the level and composition of remuneration for directors and senior executives and ensuring that such remuneration is appropriate and not excessive: ......................................................................................... [insert location] ☐ set out in our Corporate Governance Statement OR ☐ we are an externally managed entity and this recommendation is therefore not applicable 8.2 A listed entity should separately disclose its policies and practices regarding the remuneration of non-executive directors and the remuneration of executive directors and other senior executives. ☒ and we have disclosed separately our remuneration policies and practices regarding the remuneration of non-executive directors and the remuneration of executive directors and other senior executives at: Annual Report 2026 pages 16-21 ☐ set out in our Corporate Governance Statement OR ☐ we are an externally managed entity and this recommendation is therefore not applicable 8.3 A listed entity which has an equity-based remuneration scheme should: (a) have a policy on whether participants are permitted to enter into transactions (whether through the use of derivatives or otherwise) which limit the economic risk of participating in the scheme; and (b) disclose that policy or a summary of it. ☒ and we have disclosed our policy on this issue or a summary of it at: www.lycopodium.com
☐ set out in our Corporate Governance Statement OR ☐ we do not have an equity-based remuneration scheme and this recommendation is therefore not applicable OR ☐ we are an externally managed entity and this recommendation is therefore not applicable
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 13 Corporate Governance Council recommendation Where a box below is ticked, 4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement: Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are: 5
ADDITIONAL RECOMMENDATIONS THAT APPLY ONLY IN CERTAIN CASES 9.1 A listed entity with a director who does not speak the language in which board or security holder meetings are held or key corporate documents are written should disclose the processes it has in place to ensure the director understands and can contribute to the discussions at those meetings and understands and can discharge their obligations in relation to those documents. ☐ and we have disclosed information about the processes in place at: ................................................................................. [insert location] ☐ set out in our Corporate Governance Statement OR ☐ we do not have a director in this position and this recommendation is therefore not applicable OR ☐ we are an externally managed entity and this recommendation is therefore not applicable 9.2 A listed entity established outside Australia should ensure that meetings of security holders are held at a reasonable place and time. ☐ ☐ set out in our Corporate Governance Statement OR ☐ we are established in Australia and this recommendation is therefore not applicable OR ☐ we are an externally managed entity and this recommendation is therefore not applicable 9.3 A listed entity established outside Australia, and an externally managed listed entity that has an AGM, should ensure that its external auditor attends its AGM and is available to answer questions from security holders relevant to the audit. ☐ ☐ set out in our Corporate Governance Statement OR ☐ we are established in Australia and not an externally managed listed entity and this recommendation is therefore not applicable ☐ we are an externally managed entity that does not hold an AGM and this recommendation is therefore not applicable ADDITIONAL DISCLOSURES APPLICABLE TO EXTERNALLY MANAGED LISTED ENTITIES
- Alternative to Recommendation 1.1 for externally managed listed entities: The responsible entity of an externally managed listed entity should disclose: (a) the arrangements between the responsible entity and the listed entity for managing the affairs of the listed entity; and (b) the role and responsibility of the board of the responsible entity for overseeing those arrangements. ☐ and we have disclosed the information referred to in paragraphs (a) and (b) at: ......................................................................................... [insert location] ☐ set out in our Corporate Governance Statement
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 14 Corporate Governance Council recommendation Where a box below is ticked, 4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement: Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are: 5
- Alternative to Recommendations 8.1, 8.2 and 8.3 for externally managed listed entities: An externally managed listed entity should clearly disclose the terms governing the remuneration of the manager. ☐ and we have disclosed the terms governing our remuneration as manager of the entity at: ......................................................................................... [insert location] ☐ set out in our Corporate Governance Statement
Investor Presentation FY2026 19 August 2026
Change pic About Lycopodium FY26 Financial Highlights Operational Highlights Outlook & Guidance Appendix Contents
Lycopodium About
4 ABOUT US Lycopodium is a leading global engineering and project delivery organisation Founded in 1992, Lycopodium provides integrated engineering, project, construction and asset management expertise across the project lifecycle With >1,400 staff globally, Lycopodium is built upon long-serving teams of high-calibre people Lycopodium’s core capabilities span feasibility studies and advisory services through to the delivery of complex, multidisciplinary projects Current operations traverse resources, industrial processes/energy and infrastructure industries, delivering bespoke and innovative solutions Broad and diverse client base includes emerging, majors and globally diversified enterprises 18 offices globally 1,400+ people 30+ years of experience
5 •Mineralogy, metallurgy & chemistry •Process development & modelling •Pilot programmes •Mass and energy balances •HAZID/HAZOP •Dynamic simulation & digital delivery •Civil, structural, mechanical & electrical engineering (FEED) 2 •Process control & instrumentation Design and engineering solutions to optimiseROI and asset value PROCESS & ENGINEERING Ensuring assets maintained and operated within rated design window •Process plan audits & de-bottlenecking •Remote monitoring and recommendations (including in real-time) •Leveraging innovative technology, analytics and automation OPTIMISATION Concept development, preliminary analysis, delivering certainty and viability •Concept studies •Scoping studies •Preliminary economic assessment •Technical reports •Due diligence reviews •Feasibility studies (PFS, FS, DFS) 1 EVALUATION Project management, from inception to commissioning and handover •Project planning, controls, risk mitigation •Procurement, contracts management •Project and construction management (EPCM, EPC) 3 •Health, safety, environment & community •Commissioning, transition •Operations support & training DELIVERY CAPABILITIES & CORE SERVICES Focused on a culture of continuous improvement and innovation to maximise asset value 1.PFS –Pre-Feasibility Study; FS –Feasibility Study; DFS –Definitive Feasibility Study 2.FEED –Front End Engineering Design 3.EPCM –Engineering, Procurement and Construction Management; EPC –Engineering, Procurement and Construction (turnkey delivery)
6 >90 resource studies GLOBAL SCALE Lycopodium has successfully expanded its operations over time, delivering a diverse portfolio of projects globally ~$1.4 billion revenue opportunity pipeline² $661 million committed contracts $11.4 billion capital value within studies Lycopodium’s longevity and success is underpinned by long-term partnerships and a commitment to high-quality work, reflected in broad current exposure
6 (30-Jun-26) $4.9 billion managed capex of projects in delivery >50 resource projects ~9million¹ controlled service hours 2 1.Actual hours recorded –8,961,088 2.Controlled service hours, Lost Time Injury Frequency Rate (LTIFR) and Total Recordable Injury Frequency Rate (TRIFR), as at 30 June 2026 (rolling 12 months) 3.Lycopodium potential revenue pipeline of opportunities 0.00 LTIFR 2 0.67 TRIFR 2 (+19% vs 31-Dec-25) (+32% vs 31-Dec-25) (+8% vs 31-Dec-25) (>2x vs 31-Dec-25) (~70% vs 31-Dec-25) (+59% vs 31-Dec-25)
Highlights FY26 Financial
8 FY26 RESULTS Key Highlights 8 Key financial highlights $377.5 million Revenue (+11% vs FY25) $59.5 million EBITDA (-13% vs FY25) $52.5 million PBT (-13% vs FY25) $40.2 million NPAT (-5% vs FY25) 10.6% NPAT margin (-1.8pp vs FY25) 25.0% ROE (-5.4pp vs FY25) 101.1cps EPS (-5% vs FY25) 59cps (22cps interim, 37cps final) DPS (fully franked) (+69% vs FY25) $106.2 million Cash at bank (+34% vs 30-Jun-25) Minimal debt Strong balance sheet Strong operating cash flows Equity up 13% vs full year FY25 (~$170.7m vs $150.5m) Net Tangible Asset (NTA) of $3.92/share Achieved target NPAT %¹ (30-Jun-26) 1.Reflecting the Company’s long-term ~10% NPAT margin target
9 Revenue by Geography 1 Resource Studies by Commodity 2 Revenue by Client Type Resource Projects by Commodity 2 DIVERSIFIED PORTFOLIO Diversified end-market exposure across geographies, commodities and clients (FY26) 9 1.Based on project location 2.Based on number of projects, not value of projects 3.‘Other’ includes Rare Earths, Titanium, Graphite, Niobium, Cyanide, Fluorite, Cement 4.‘Other’ Rare Earths, Iron Ore 55% 32% 13% EmergingMajorGlobally Diversified 34 58% 24% 11% 7% AfricaAPACAmericasOther GoldCopperUraniumDiamondsSilverLithiumOther GoldCopperLithiumUraniumDiamondsCementOther
Highlights Operational
11 OPERATIONAL HIGHLIGHTS Current notable project and operational highlights 11 Recent awards and early phase work •San Cristóbal (Silver, Bolivia, Minera San Cristóbal S.A.) •Katanning Early Works (Gold, Australia, Ausgold) •Pilgangoora Plant Expansion (Lithium, Australia, PLS Group) •Havieron Early Works (Gold-Copper, Australia, Greatland) •Assafou-Dibibango (Gold, Côte d'Ivoire, Endeavour Mining) •Doropo (Gold, Côte d'Ivoire, Resolute) •Iguidi (Gold, Mauritania, Emiral Resources) STUDIES –PIPELINE IS STRONG Project Highlights Operational Update Refinement of regional approach to management across three operational hubs supports our One Lycopodiumphilosophy, enabling us to: •Engage more effectively with clients •Access new market opportunities, supporting structured growth across key markets where significant opportunities are identified, e.g. the Americas •Leverage local expertise APAC •Continuing to service clients operating across Africa, and have secured significant work closer to home, providing services for a number of projects being delivered in Western Australia Africa •African hub, based in Cape Town, is providing a critical role in supporting projects in delivery across the continent, leveraging the local expertise and capability that exists in key locations, including Namibia, amongst others •LPN Dry Mining Services –strategic, two-year pilot project for a modular dry mining facility in Namibia for Namdeb, broadening our service offering Americas •Significant increase in activity over the past 12 months, with a number of major projects currently in delivery out of Toronto •See slide 12 for additional Americas detail •Tulu Kapi (Gold, Ethiopia, KEFI Gold and Copper) •Blackwater Expansion (Gold, Canada, Artemis Gold) •Winu –IMT (Copper-Gold, Australia, Rio Tinto) Projects ramping up WORLD-CLASS PROJECTS Lithium 6.9410 3 LiAu Gold 196.97 79 Cu Copper 63.546 29
12 AMERICAS OPPORTUNITY Disciplined geographic expansion providing key growth pillar PHASE 1 Establish beachhead Toronto office •Toronto office established 2011 •Commenced with a staff of less than 10 people, today employs 180 people •Long-term strategy to establish foothold in Canada, further expanded with Vancouver office PHASE 2 Expand geographically SAXUM acquisition, 7 office locations •SAXUM: 60% acquired (A$10.8m, Feb 2025), with path to 100%, 30-year track record, 100+ employees • Canada: Toronto (expanded); Vancouver (Apr 2025) • Peru: Lima - 3×growth since Dec 2023 • Argentina: Tucumán (SAXUM HQ) and Buenos Aires •Brazil: Belo Horizonte • USA: Irving, Texas - mineral resources, cement & lime PHASE 3 Convert pipeline new markets, existing clients •Award of Blackwater EP2 EPCM is particularly meaningful as represents material domestic project to be delivered by Canadian-based business •Tendering across Argentina, Bolivia, Brazil, Peru, Colombia •Many asset owners are already Lycopodium clients •Proof points: Blackwater Expansion EPCM (Au), San Cristóbal EPCM (Ag) Strategic expansion throughout the Americas provides Lycopodium with key growth pillar in the medium to long-term, via deliberate, phased approach: 1.Based on project location >40% INCREASE in total addressable market 11% OF TOTAL REVENUE from the Americas¹ (+ growing) 5+ COUNTRIES currently in the tendering pipeline AMERICAS REVENUE¹ ~A$40m
13 ProjectClientCommodityLocation San Cristóbal Minera San Cristóbal S.A.SilverBolivia HavieronGreatlandGold, CopperWestern Australia KatanningAusgoldGoldWestern Australia Assafou-DibibangoEndeavour MiningGoldCôte d'Ivoire DoropoResoluteGoldCôte d'Ivoire Pilgangoora Plant ExpansionPLS GroupLithiumWestern Australia Blackwater ExpansionArtemis GoldGoldCanada Tulu KapiKEFI Gold and CopperGoldEthiopia WinuRio TintoCopper, GoldWestern Australia ToliaraBase ResourcesMineral SandsMadagascar IguidiEmiral ResourcesGold Mauritania ProjectClientCommodityLocation Koné Montage GoldGoldCôte d’Ivoire YanqulMazoonMiningCopperOman BaomahunFG GoldGoldSierra Leone NyanzagaPerseus MiningGoldTanzania Twin HillsOsino ResourcesGoldNamibia Bomboré Hard Rock Stage 2Orezone GoldGoldBurkina Faso ProjectClientCommodityLocation CGP3Talison LithiumLithiumWestern Australia Bomboré Hard Rock Stage 1 Orezone GoldGoldBurkina Faso Ahafo NorthNewmontGoldGhana BotoManagemGoldSenegal RESOURCES –MAJOR PROJECT STATUS Current WIH includes 90+ studies, through to projects in delivery and completion¹ Engineering/early stagesOnsite delivery –progressingCommissioning/completed 1.Not exhaustive list
14 PEOPLE AND SYSTEMS Providing our people with the infrastructure and tools to succeed Systems Infrastructure Learning and Development Long-term strategy of developing systems infrastructure required to facilitate global operations is providing a standardised platform across all operating entities and supporting workplace efficiencies and workshare Continuing to provide the learning and development support required to enable our people to grow their career, with a suite of tailored programs and L&D tools focused on developing both technical and soft skills
15 Ongoing support of communities in which the Company lives and works, through the Lycopodium Foundation and the charitable spirit of our people Support aligned with Lycopodium’s intrinsic philosophies and values: Social development Innovative thinking EducationEnvironmental sustainability COMMUNITY ENGAGEMENT Supporting communities through Lycopodium Foundation 15
Guidance Outlook &
17 Supported by macroeconomic and industry drivers 17 As it relates to FY27, Lycopodium provides the following observations: Overall demand drivers for Lycopodium’s engineering and delivery solutions remain strong, supported by the Company’s bespoke and modular engineering capabilities and expansion of our geographic footprint. Resources ‘core’ remains robust –Lycopodium is recognised as an expert in project delivery across commodities where outlook remains positive, including: o Gold –sustained demand, underpinned by persistent geopolitical uncertainty; oCritical minerals –with elevated renewable energy as well as electrification-related demand; and o Uranium–global demand growing, with policy shifting toward nuclear as a reliable, low-carbon energy alternative. Secured pipeline bolstered by new wins –including those recently announced: Doropo, Katanning, Pilgangoora, Blackwater Expansion, San Cristóbal –supporting sustained revenue performance in future years. Expanding infrastructure-related demand also supportive –ongoing Australian Government investment in passenger and freight rail infrastructure, including network expansion projects and asset renewal and replacement program. Geographic diversification strategy beginning to deliver results –Lycopodium continues to execute against its stated objective of diversifying globally, with key focus on expanding penetration in the Americas. In doing so, the Company will proactively manage its workforce, project delivery pipeline and cost base, leveraging its reach to access new and existing markets. Contract mix –predominantly EPCM, however the order book reflects a blend of contract styles in FY27. FY27 OUTLOOK
18 FY27 GUIDANCE Growing volume of work underpinning future earnings 18 $540m&$580m Between Revenue $54m&$58m¹ Between Net Profit After Tax (NPAT) The Company will continue to update shareholders as the financial year progresses Considering the FY27 outlook, Lycopodium provides the following full year FY27 guidance: +50% vs FY26² +40% vs FY26² 1.Reflecting the Company’s long-term ~10% NPAT margin target 2.Assuming mid-point of updated FY27 guided range
19 Deep engineering expertise Long-serving knowledgeable teams of high calibre personnel delivering innovative key services Strong history of execution Sustainable financial and operational performance underpinned by aligned Board & Management (~30% TSO) Blue chip clients Diverse list of longstanding clients, mutually respected relationships, leaders in respective fields (approx. two thirds revenue from repeat clients) Geographically diversified Focused on achieving broader geographic reach globally and in turn leveraging emerging prospects and opportunities Disciplined risk management High-quality, balanced portfolio (EPCM vs EPC mix), conservative and sustainable approach Capital light approach Managing local workforce on behalf of clients, limited ‘on ground’ personnel Commodity diversification Favourable demand across a range of commodities, further supported by new industries (e.g. energy transition) Undemanding valuation Offering history of sustainable growth, attractive dividend yield and elevated ROE LYCOPODIUM SUMMARY Secure, stable and sustainable 19 19
Appendix
21 Continued focus on ensuring we have the right people, with the required skills and experience •Preserve culture via leadership, management, tools and performance measures •Effective succession planning •Drive professional development across technical, project, management and leadership skills •Build upon leading reputation to retain and attract top talent Leverage tools, systems and data (i.e.ERP) for insights, efficiency and optimisation •Informed decision making via investment in global systems •Increased productivity through analysis and insights from vast proprietary data and digital delivery capabilities •Improved project/corporate memory via standardisation of procedures and data sets •Continuous improvement and adoption of new technologies for further optimisation Enhance technical capability and accountability, foster innovation, and disciplined approach to risk •Continue to build market leading technical capability and reputation for engineering excellence •Focus on quality and accountability and effective utilisation of internal Technical Advisory Group •Consider and commercialise market innovative ideas for Company and client benefit •Prioritise high-quality work
PERTH, 19 August 2026
Lycopodium Limited (“ASX: LYL”, “Lycopodium” or “the Company”), a global leader in integrated
engineering, project, construction and asset management, is pleased to have released its financial
results today for the full year ended 30 June 2026 (“FY26”).
FY26 Highlights:
• Successfully delivered results within the guidance range¹
• Revenue of $377.5 million
• EBITDA of $59.5 million
• NPAT of $40.2 million
• EPS of 101.1 cents per share
• Fully franked final dividend of 37 cents per share, delivering full-year DPS of 59 cps
• Healthy cash balance of $106.2 million as at 30 June 2026
• FY27 guidance:
o Revenue of $540 - $580 million; and
o Net profit after tax (NPAT) of $54 - $58 million
• Committed contracts of $661 million
• Webinar to be held 11:00am AEST today, Wednesday 19 August 2026 (
click to register)
Commenting on the results, Lycopodium’s Managing Director & CEO, Peter De Leo, said:
“FY26 has been another successful year for the Company, with an expanded geographic reach and the
continued delivery of high-quality studies and projects for our clients globally.”
Results Summary During FY26, Lycopodium generated revenue of $377.5 million, with the ongoing delivery of a significant portfolio of projects across the globe and the commencement of new work won during the period. Net profit after tax (NPAT) was $40.2 million, reflecting NPAT margin of 10.6%. Both revenue and NPAT achieved in FY26 are within the guidance range provided in February 2026 1 . As a result, the Board has declared a fully franked final dividend of 37 cents per share, payable on 2 October 2026, bringing the full-year dividend to 59 cents per share, reflecting a 60% full-year payout ratio and a 69% increase in full-year dividend vs FY25. Company Highlights To support its global operations, the Company has evolved its operating model over the past year, adopting a regional approach spanning three core hubs – APAC based in Perth, the Americas based in Toronto, and Africa based in Cape Town – supplemented with offices across these regions. This strategy has enhanced the Company’s ability to engage with clients and access new market opportunities. Importantly, it leverages local expertise and supports structured growth across key markets where significant opportunities are identified, for example, the Americas. In this regard, there has been a marked increase in activity over the past 12 months within the Americas hub, with a number of major projects currently in delivery out of Toronto. Furthermore, the
1 FY26 Full Year Guidance: Revenue $370m - $410m, NPAT $37m - $41m ( 18 February 2026).
Lycopodium Limited ABN 83 098 556 159 W lycopodium.com
Level 5, 1 Adelaide Terrace, East Perth WA 6004, Australia T +61 8 6210 5222
addition of SAXUM, the Argentinian-based business Lycopodium acquired a majority shareholding in
in 2025, has facilitated ingress into Latin America. Having a physical presence in this region is
presenting new opportunities that would not have otherwise been accessible.
Elsewhere, the African hub is also providing a critical role in supporting projects in delivery across the
continent, leveraging the local expertise and capability that exists in key locations, including Namibia,
amongst others. Additionally, from an APAC perspective, the Company is continuing to service clients
operating across Africa, in addition to securing significant work closer to home, providing services for
a number of projects being delivered in Western Australia.
In the longer term, the Company expects to see a more regionally balanced portfolio of studies and
projects across its global operations. Focus therefore remains on continuing to grow capacity and
capabilities across the regional centres to support current and forecast work-in-hand.
Operational Highlights
FY26 saw the successful completion of several major projects, including the Ahafo North Project in
Ghana (Newmont), the Chemical Grade Processing Plant #3 Project in Western Australia (Talison
Lithium), the Boto Gold Project in Senegal (Managem Group) and the Bomboré Hard Rock (Stage 1)
Project in Burkina Faso (Orezone).
“Over the period, we successfully managed 9 million controlled service hours across our operations,
recording a Lost Time Injury Frequency Rate (LTIFR) of zero. This outstanding result is reflective of the
commitment of our people across the business to fostering a safe working environment and is a credit to
each and every one of them,” said Mr De Leo.
Other significant projects ongoing throughout the year include the Yanqul Copper-Gold Project in
Oman (Mazoon Mining), the Baomahun Gold Project in Sierra Leone (FG Gold), the Koné Gold Project
in Côte d'Ivoire (Montage Gold), the Twin Hills Gold Project in Namibia (Osino Resources), the
Bomboré Hard Rock (Stage 2) Project in Burkina Faso (Orezone), the Winu Copper-Gold Project in
Western Australia (Rio Tinto), the Nyanzaga Gold Project in Tanzania (Perseus), and the Blackwater
Expansion Project (Phase 1A, EP2 and Phase 3) in Canada (Artemis Gold).
“Blackwater is a world-class facility in a tier-one mining jurisdiction, and our involvement in the mine’s
expansion is particularly meaningful, given it represents a material domestic project to be delivered by
our Canadian-based business,“ said Mr De Leo.
Several new projects have been secured over the past few months, including the Tulu Kapi Gold
Project in Ethiopia (KEFI Gold and Copper), the Doropo Gold Project in Côte d'Ivoire (Resolute Mining),
the Katanning Gold Project Early Works in Western Australia (Ausgold), the Pilgangoora P2000
Expansion Project in Western Australia (PLS Group), and the San Cristóbal Silver Oxide Project in
Bolivia (Minera San Cristóbal S.A.), with these projects set to ramp up moving into FY27.
Commenting on the FY27 outlook, Mr De Leo said: “We had expected several of these projects to land
earlier this year, but the extended duration of the conflict in the Middle East and the uncertainty
surrounding its resolution, has delayed decision making and impacted the award and commencement of
new projects. We had initially expected FY27 to be a record year for the Company, with results
surpassing recent years, and that is even more pronounced now, with a suite of new projects recently
awarded and in execution.”
LPN Dry Mining Services, Lycopodium’s joint venture with Piacentini & Son, a specialised earthmoving
and mining equipment company based in Western Australia, is providing services to Namdeb
Diamond Corporation in Namibia, with the establishment and operation of a pilot project involving a
modular dry mining facility for the stripping of overburden, under a two-year contract.
Lycopodium Limited ABN 83 098 556 159 W lycopodium.com
Level 5, 1 Adelaide Terrace, East Perth WA 6004, Australia T +61 8 6210 5222
“This strategic work is another example of Lycopodium broadening its service offering into adjacent
fields and establishing recurring revenue streams,” said Mr De Leo.
The Company’s study pipeline remains strong and continues to lay a solid foundation for future
project execution work, with the number of quality projects in study phase presenting a positive sign
for Lycopodium’s future project pipeline.
Lycopodium’s wholly owned subsidiary, Orway Mineral Consultants (OMC), continues to be a critical
technical component of its Resources related capabilities. Considered a global leader in comminution
circuit design and optimisation, OMC provides specialist services in flowsheet development,
optimisation and process design, as well as supporting clients to maximise operational performance
post project completion.
In Rail Infrastructure, Lycopodium is known for its expertise in the provision of design, engineering,
technical advisory and Rail Infrastructure Management (RIM) services for greenfield and brownfield
rail projects across Australia, servicing both government and private sector clients. During FY26, the
Company worked with the Australian Rail Track Corporation (ARTC) to undertake feasibility and
concept design services for two crossing loop upgrades on the Broken Hill line in New South Wales
under the Network Investment Program. In Western Australia, the Company worked with Arc
Infrastructure in the delivery of its Agricultural Supply Chain Improvements Project, providing track
design services for upgrades between Carnamah and Mingenew.
Outlook and Guidance
As it relates to the FY27 outlook, overall demand drivers for Lycopodium’s engineering and project
delivery solutions remain strong, supported by the Company’s bespoke and modular engineering
capabilities and expansion of its geographic footprint.
Lycopodium’s resources ‘core’ remains robust with the Company’s secured pipeline bolstered by new
contract wins, several of which have been announced post 30 June financial year end. Additionally,
expanding infrastructure-related demand is also supportive, along with the Company’s stated
geographic diversification strategy which is beginning to deliver results (refer FY26 Investor
Presentation for additional outlook commentary).
On the basis of current work-in-hand and a strong future pipeline, the Company provides the
following guidance for FY27:
• Revenue of $540 – $ 580 million; and
• Net profit after tax (NPAT) of $54 – $ 58 million, reflecting the Company’s long-term ~10%
NPAT margin target.
The Company will continue to update the market accordingly and will provide further guidance at its
Annual General Meeting in November. The current view based on the business outlook and demand
for services indicates the Company will return a strong financial performance for FY27, with results
surpassing recent years.
Results Webinar
The Company will host an investor webinar to discuss the results with Managing Director & CEO Peter
De Leo, and Chief Financial Officer Justine Campbell. The webinar will be held at 11:00am AEST
(9:00am AWST) today, Wednesday 19 August 2026.
Investors and interested parties can register for the webinar here:
click to register
Lycopodium Limited ABN 83 098 556 159 W lycopodium.com
Level 5, 1 Adelaide Terrace, East Perth WA 6004, Australia T +61 8 6210 5222
PERTH, 18 August 2026 Lycopodium Limited (“ASX: LYL”, “Lycopodium” or “the Company”), a global leader in integrated engineering, project, construction and asset management, is pleased to announce it has been awarded the Engineering, Procurement and Construction Management (EPCM) contract for the development of a new silver oxide plant, adjacent to the existing sulphides plant, at the San Cristóbal Mine in Bolivia. The EPCM contract is valued at approximately A$37 million. Located in Bolivia’s southwestern Potosí Department, the San Cristóbal Mine is a globally significant open-pit silver, zinc, and lead mining operation. Lycopodium will provide EPCM services for a new 15,000 tonnes per day (tpd) plant to treat oxidised material and produce silver doré. The project, which is still subject to a final investment decision, is a brownfields expansion to the currently operating 52,000 tpd process plant that is treating sulphide ores from a polymetallic ore body and producing zinc-silver and lead-silver concentrates. On completion of the project, both plants will operate simultaneously. Works will commence immediately, with completion anticipated in 2030. Lycopodium’s Managing Director and CEO, Peter De Leo, said: “We are extremely pleased to be given this opportunity to work with Minera San Cristóbal SA in the development of the San Cristóbal Mine. This strategic project positions the mine to become a significant silver producer on a global scale and includes challenges of design and construction at a high altitude, at 4,000 metres above sea level. Execution of the project will include significant collaboration across our Americas team, with input from our Toronto, SAXUM (Argentina) and Lima offices.”
PERTH, 7 August 2026 Lycopodium Limited (“ASX: LYL”, “Lycopodium” or “the Company”), a global leader in integrated engineering, project, construction and asset management, is pleased to announce it has been awarded the Engineering, Procurement and Construction Management (EPCM) contract for Artemis Gold’s Expanded Phase 2 (EP2) Project at the Blackwater Mine in Canada. The EPCM contract is valued at approximately A$93 million (calculated at an exchange rate of A$1 AUD = 0.985 CAD) within Artemis Gold's overall EP2 budget. Blackwater is an open-pit truck and shovel gold and silver mine located in central British Columbia, approximately 160 kilometres southwest of Prince George and 446 kilometres northeast of Vancouver. Commercial production commenced at the mine in May 2025, and it is anticipated at the conclusion of the mine’s multi-phase expansion program, total production capacity will be 21 million tonnes per annum (Mtpa), making it one of the three largest gold mines in Canada. EP2 will add 13 Mtpa of throughput capacity, which combined with the Phase 1A project (8 Mtpa), will increase the total throughput capacity of the Blackwater Mine to 21 Mtpa. Lycopodium has been providing EPCM services for the delivery of Phase 1A and was also involved in the earlier stages of the EP2 development, preparing the Feasibility Study and providing Front End Engineering and Design (FEED) services for the new plant. EP2 early works construction activities are well underway, including earthworks for the new plant site. Artemis Gold recently announced the commencement of major works construction with the first concrete pour for the ball mill foundations completed ahead of schedule. Lycopodium’s Managing Director and CEO, Peter De Leo, said: “We are very pleased to be given this opportunity to continue to work with Artemis Gold in the further development of the Blackwater Mine. Blackwater is a world-class facility in a tier-one mining jurisdiction, and our involvement in the mine’s expansion is particularly meaningful, given it represents a material domestic project to be delivered by our Canadian-based business.”
PERTH, 29 July 2026 Lycopodium Limited (“ASX: LYL”, “Lycopodium” or “the Company”), a global leader in integrated engineering, project, construction and asset management, is pleased to announce it has been awarded the Detailed Engineering Services contract by Pilgangoora Operations Pty Ltd, a subsidiary of PLS Group Limited (PLS), for the design of the Wet Plant for PLS to progress to final investment decision (FID) for the P2000 Expansion Project at the Pilgangoora Operation in Western Australia. The contract is valued at ~A$22 million, with work commencing immediately. This award follows Lycopodium’s delivery of the Front-End Engineering Design (FEED) for the Wet Plant. The Pilgangoora Operation is comprised of two processing plants, the Pilgan and Ngungaju plants, located approximately 140 kilometres southeast of Port Hedland in Western Australia’s Pilbara region. Pilgangoora is one of the world’s largest hard rock lithium operations. The P2000 Expansion Project, if approved by the PLS Board, will involve the construction of a new processing plant at the Pilgangoora Operation to expand production capacity to approximately 2 million tonnes per annum of lithium spodumene concentrate. The new processing facility and crushing circuit will be located to the east of the existing Pilgan plant. Lycopodium’s Managing Director and CEO, Peter De Leo, said: “Lycopodium has been working with PLS in the ongoing development of its flagship Pilgangoora Operation for a number of years now, including through various stages of expansion and the Mid-Stream Demonstration Plant Project, and we are extremely pleased to continue our involvement with this world-class operation that provides vital input into the global energy transition.”
PERTH, 27 July 2026
Lycopodium Limited (ASX: LYL) (“Lycopodium” or “the Company”), a global leader in integrated
engineering, construction and asset management, is pleased to advise it will release its full year results
for the period ended 30 June 2026 (“FY26”) on Wednesday, 19 August 2026.
The Company will host a webinar with Managing Director and Chief Executive Officer, Peter De Leo
and Chief Financial Officer, Justine Campbell. The webinar will be hosted at 11:00am AEST / 9:00am
AWST on the same day, Wednesday 19 August. Register for the webinar via the link below:
https://events.teams.microsoft.com/event/92b08c70-e7cd-44a2-90e1-9f0a5d99a9b2@fa978af0-9d59-
46d1-82f1-eada6856000d
Following the presentation, participants will have the opportunity to ask questions.
Investors may submit questions prior to the call to
[email protected] or do so via the
Q&A function in Teams.
PERTH, 7 July 2026
Lycopodium Limited (“ASX: LYL”, “Lycopodium” or “the Company”), a global leader in integrated
engineering, project, construction and asset management, is pleased to advise it has been announced
as the preferred Engineering, Procurement and Construction (EPC) contractor for the development of
Ausgold Limited’s (“Ausgold”) Katanning Gold Project in Western Australia.
The Company has been awarded an Early Works Agreement to commence detailed engineering
activities, valued at approximately A$6.0 million. The early works include progression of detailed
engineering, optimisation of project execution planning, refinement of construction methodologies
and purchase of vendor data for procurement packages to support an efficient transition into full
project delivery following a planned final investment decision (FID) by the end of 2026, with first gold
production anticipated in mid-2028.
The Katanning Gold Project is located 275 kilometres south-east of Perth and 40 kilometres north-east
of the wheatbelt town of Katanning. It encompasses the engineering, design, procurement,
construction and commissioning of a 3.9 Mtpa conventional carbon-in-leach (CIL) processing plant
and associated non-process infrastructure, including 11kV power reticulation, water supply, tailings
pipeline and decant return. The ore will be mined through a series of open pits over an initial 10-year
mine life.
Lycopodium’s Managing Director and CEO, Peter De Leo, said: “The Katanning Gold Project represents
one of Western Australia’s largest undeveloped gold resources, and as a Perth-headquartered company,
we are extremely pleased to have been given the opportunity to deliver this significant greenfield gold
project right here in WA.”
PERTH, 23 June 2026
Lycopodium Limited (“ASX: LYL”, “Lycopodium” or “the Company”), a global leader in integrated
engineering, project, construction and asset management, is pleased to announce it has been
awarded the Design, Supply and Construction Management Services (EPCM) contract for the
development of Resolute Mining’s (“Resolute”) Doropo Gold Project in Côte d’Ivoire.
The work is valued at approximately A$196 million over the term of the EPCM contract and includes
the provision of Engineering and Procurement Management Services and Equipment Supply and the
provision of Construction Management Services for a 4.9 Mtpa processing plant and associated non-
process infrastructure.
The delivery of the project commenced following receipt of a Limited Notice of Award in April 2026.
Doropo is located in north-eastern Côte d’Ivoire, within the Bounkani Region, approximately 450
kilometres northeast of Abidjan.
Lycopodium has been involved with the project through various study phases, with the delivery of the
NI 43-101 Technical Report in 2023 and the Definitive Feasibility Study Update in 2025. Most recently,
Lycopodium completed the Front-End Engineering Design (FEED) services for the project.
Lycopodium’s EPCM scope includes the engineering, design, procurement, equipment supply,
construction management and commissioning of the processing plant and associated non-process
infrastructure, including 11kV power reticulation, water supply, tailings pipeline and decant return.
The project comprises a series of open pit mines, with ore from the multiple deposits mined and
processed through the central carbon-in-leach (CIL) processing plant over an expected mine life of
approximately 13 years.
Lycopodium’s Managing Director and CEO, Peter De Leo, said: “With our extensive experience in
successfully delivering gold projects in West Africa for more than three decades, we are very pleased to
be given this opportunity to work with Resolute in the development of this large-scale, high-value
project, which will be a significant addition to Côte d’Ivoire’s growing gold sector.”
In consideration of this award, work-in-hand, and additional anticipated new work currently in the late
stages of negotiation, the Company intends to provide FY27 guidance on 19 August 2026, when the
FY26 full year results are released.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Lycopodium Limited
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| AVDS | 0.02% | 5,367 | $ 72.285K | Nov 16, 2026 |
| AVSD | 0.01% | 2,541 | $ 34.223K | Nov 16, 2026 |
| DFSI | 0.00% | 2,290 | $ 32.718K | Nov 12, 2026 |
| DFIC | 0.00% | 25,569 | $ 365.314K | Nov 12, 2026 |
| DFIS | 0.00% | 8,455 | $ 120.8K | Nov 12, 2026 |
| DXIV | 0.00% | 329 | $ 4,700.54 | Nov 12, 2026 |
| DFAX | 0.00% | 6,098 | $ 87.124K | Nov 12, 2026 |
| AVDE | 0.00% | 19,357 | $ 260.708K | Nov 16, 2026 |
| AVDV | 0.00% | 37,985 | $ 511.598K | Nov 16, 2026 |